KR20200011243A - Composition for anti-oxidation, anti-inflammation, or anti-wrinkle comprising extract of green ball apple peel - Google Patents
Composition for anti-oxidation, anti-inflammation, or anti-wrinkle comprising extract of green ball apple peel Download PDFInfo
- Publication number
- KR20200011243A KR20200011243A KR1020180086094A KR20180086094A KR20200011243A KR 20200011243 A KR20200011243 A KR 20200011243A KR 1020180086094 A KR1020180086094 A KR 1020180086094A KR 20180086094 A KR20180086094 A KR 20180086094A KR 20200011243 A KR20200011243 A KR 20200011243A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- extract
- greenball
- apple peel
- antioxidant
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 116
- 239000000203 mixture Substances 0.000 title claims abstract description 67
- 230000001153 anti-wrinkle effect Effects 0.000 title claims abstract description 19
- 206010061218 Inflammation Diseases 0.000 title description 6
- 230000003064 anti-oxidating effect Effects 0.000 title 1
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 48
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 45
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 41
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 33
- 239000002537 cosmetic Substances 0.000 claims abstract description 31
- 102000029816 Collagenase Human genes 0.000 claims abstract description 22
- 108060005980 Collagenase Proteins 0.000 claims abstract description 22
- 108010003272 Hyaluronate lyase Proteins 0.000 claims abstract description 21
- 102000001974 Hyaluronidases Human genes 0.000 claims abstract description 21
- 229960002424 collagenase Drugs 0.000 claims abstract description 21
- 229960002773 hyaluronidase Drugs 0.000 claims abstract description 21
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 21
- 102000016387 Pancreatic elastase Human genes 0.000 claims abstract description 15
- 108010067372 Pancreatic elastase Proteins 0.000 claims abstract description 15
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 235000013376 functional food Nutrition 0.000 claims abstract description 11
- 230000036541 health Effects 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 57
- 238000000034 method Methods 0.000 claims description 41
- 230000005764 inhibitory process Effects 0.000 claims description 28
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 24
- 230000037303 wrinkles Effects 0.000 claims description 21
- 239000000524 Thiobarbituric Acid Reactive Substance Substances 0.000 claims description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 claims description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 230000006872 improvement Effects 0.000 claims description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 10
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 claims description 9
- 150000001298 alcohols Chemical class 0.000 claims description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 6
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 claims description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 6
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 5
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 5
- HQFLTUZKIRYQSP-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N(CC)CSC2=C1 HQFLTUZKIRYQSP-UHFFFAOYSA-N 0.000 claims description 4
- 235000015872 dietary supplement Nutrition 0.000 claims 2
- 239000002417 nutraceutical Substances 0.000 claims 1
- 235000021436 nutraceutical agent Nutrition 0.000 claims 1
- 244000070406 Malus silvestris Species 0.000 abstract description 146
- 235000015103 Malus silvestris Nutrition 0.000 abstract description 114
- 235000011430 Malus pumila Nutrition 0.000 abstract description 110
- 235000021016 apples Nutrition 0.000 abstract description 40
- 230000000694 effects Effects 0.000 abstract description 38
- 102000016942 Elastin Human genes 0.000 abstract description 8
- 108010014258 Elastin Proteins 0.000 abstract description 8
- 229920002549 elastin Polymers 0.000 abstract description 8
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 abstract description 7
- 230000001965 increasing effect Effects 0.000 abstract description 4
- 241000220225 Malus Species 0.000 abstract description 3
- 230000028709 inflammatory response Effects 0.000 abstract description 3
- 241000894007 species Species 0.000 abstract 1
- -1 polyphenol compounds Chemical class 0.000 description 68
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 63
- 235000013824 polyphenols Nutrition 0.000 description 56
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 52
- 235000006708 antioxidants Nutrition 0.000 description 36
- 239000000469 ethanolic extract Substances 0.000 description 35
- 235000019441 ethanol Nutrition 0.000 description 28
- 235000014113 dietary fatty acids Nutrition 0.000 description 18
- 239000000194 fatty acid Substances 0.000 description 18
- 229930195729 fatty acid Natural products 0.000 description 18
- 230000001766 physiological effect Effects 0.000 description 18
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 17
- 239000003921 oil Substances 0.000 description 17
- 230000002292 Radical scavenging effect Effects 0.000 description 16
- 239000002253 acid Substances 0.000 description 16
- 238000000605 extraction Methods 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- 239000007787 solid Substances 0.000 description 16
- 210000003491 skin Anatomy 0.000 description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 13
- 150000002989 phenols Chemical class 0.000 description 13
- 150000003839 salts Chemical class 0.000 description 13
- 229940088594 vitamin Drugs 0.000 description 13
- 229930003231 vitamin Natural products 0.000 description 13
- 235000013343 vitamin Nutrition 0.000 description 13
- 239000011782 vitamin Substances 0.000 description 13
- 239000006210 lotion Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 239000003925 fat Substances 0.000 description 11
- 235000019197 fats Nutrition 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 102000008186 Collagen Human genes 0.000 description 9
- 108010035532 Collagen Proteins 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 9
- 229920001436 collagen Polymers 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 239000006071 cream Substances 0.000 description 8
- 239000003085 diluting agent Substances 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 239000000546 pharmaceutical excipient Substances 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 241001474374 Blennius Species 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 235000013355 food flavoring agent Nutrition 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 6
- 244000081841 Malus domestica Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 229920002674 hyaluronan Polymers 0.000 description 6
- 229960003160 hyaluronic acid Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 239000000600 sorbitol Substances 0.000 description 6
- 229960002920 sorbitol Drugs 0.000 description 6
- 235000010356 sorbitol Nutrition 0.000 description 6
- 239000000454 talc Substances 0.000 description 6
- 229910052623 talc Inorganic materials 0.000 description 6
- 235000012222 talc Nutrition 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 239000003906 humectant Substances 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 235000015424 sodium Nutrition 0.000 description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000001023 inorganic pigment Substances 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- CRSOQBOWXPBRES-UHFFFAOYSA-N neopentane Chemical compound CC(C)(C)C CRSOQBOWXPBRES-UHFFFAOYSA-N 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 239000012860 organic pigment Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920000136 polysorbate Polymers 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 239000004386 Erythritol Substances 0.000 description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 235000010724 Wisteria floribunda Nutrition 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 235000012216 bentonite Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 235000012241 calcium silicate Nutrition 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000002849 elastaseinhibitory effect Effects 0.000 description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 3
- 229940009714 erythritol Drugs 0.000 description 3
- 235000019414 erythritol Nutrition 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 229960001031 glucose Drugs 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 229960001855 mannitol Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 229940049964 oleate Drugs 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 229920000223 polyglycerol Polymers 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 150000003408 sphingolipids Chemical class 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 229940032147 starch Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 229940011671 vitamin b6 Drugs 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- 235000014692 zinc oxide Nutrition 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 2
- UWNADWZGEHDQAB-UHFFFAOYSA-N 2,5-dimethylhexane Chemical group CC(C)CCC(C)C UWNADWZGEHDQAB-UHFFFAOYSA-N 0.000 description 2
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 2
- 102000005720 Glutathione transferase Human genes 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- FHKPLLOSJHHKNU-INIZCTEOSA-N [(3S)-3-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxypyrrolidin-1-yl]-(oxan-4-yl)methanone Chemical compound C(C)N1N=CC(=C1C)C=1N(C2=NC=NC(=C2N=1)O[C@@H]1CN(CC1)C(=O)C1CCOCC1)C FHKPLLOSJHHKNU-INIZCTEOSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 235000019987 cider Nutrition 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 2
- 229940093471 ethyl oleate Drugs 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 235000019488 nut oil Nutrition 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 235000007686 potassium Nutrition 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 229940117986 sulfobetaine Drugs 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristoyl-sn-glycerol Natural products CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- WFXHUBZUIFLWCV-UHFFFAOYSA-N (2,2-dimethyl-3-octanoyloxypropyl) octanoate Chemical compound CCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCC WFXHUBZUIFLWCV-UHFFFAOYSA-N 0.000 description 1
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- BOCBOJPUWMTAJB-UHFFFAOYSA-N (2-butylphenyl) 2-hydroxybenzoate Chemical compound CCCCC1=CC=CC=C1OC(=O)C1=CC=CC=C1O BOCBOJPUWMTAJB-UHFFFAOYSA-N 0.000 description 1
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OUZOBPPZPCBJAR-UHFFFAOYSA-N 14-methylpentadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C OUZOBPPZPCBJAR-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- WPIOBXGJZUSKGK-UHFFFAOYSA-N 16-methylheptadecyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C WPIOBXGJZUSKGK-UHFFFAOYSA-N 0.000 description 1
- MVUWRLHKGKEGSS-UHFFFAOYSA-N 16-methylheptadecyl octanoate Chemical compound CCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C MVUWRLHKGKEGSS-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- QZJDYFVPLXBWTK-UHFFFAOYSA-N 2-(diethylamino)ethyl octadecanoate Chemical class CCCCCCCCCCCCCCCCCC(=O)OCCN(CC)CC QZJDYFVPLXBWTK-UHFFFAOYSA-N 0.000 description 1
- ZMXUPLNMYABPEB-UHFFFAOYSA-N 2-[[2-(dodecanoylamino)acetyl]amino]acetic acid Chemical compound CCCCCCCCCCCC(=O)NCC(=O)NCC(O)=O ZMXUPLNMYABPEB-UHFFFAOYSA-N 0.000 description 1
- QUBNFZFTFXTLKH-UHFFFAOYSA-N 2-aminododecanoic acid Chemical compound CCCCCCCCCCC(N)C(O)=O QUBNFZFTFXTLKH-UHFFFAOYSA-N 0.000 description 1
- AKVBCGQVQXPRLD-UHFFFAOYSA-N 2-aminooctanoic acid Chemical compound CCCCCCC(N)C(O)=O AKVBCGQVQXPRLD-UHFFFAOYSA-N 0.000 description 1
- KNEFRHCUYCDKRK-UHFFFAOYSA-N 2-benzyl-3-phenylprop-2-enoic acid Chemical compound C=1C=CC=CC=1C=C(C(=O)O)CC1=CC=CC=C1 KNEFRHCUYCDKRK-UHFFFAOYSA-N 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- DIFKERPSKZJYML-UHFFFAOYSA-N 2-ethyl-2-(hydroxymethyl)propane-1,3-diol;octadecanoic acid Chemical compound CCC(CO)(CO)CO.CCCCCCCCCCCCCCCCCC(O)=O DIFKERPSKZJYML-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- HTNFLUQQANUSLR-UHFFFAOYSA-N 2-octanoyloxyethyl octanoate Chemical compound CCCCCCCC(=O)OCCOC(=O)CCCCCCC HTNFLUQQANUSLR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- QULIOZDJZXKLNY-UHFFFAOYSA-N 3,4,5-trihydroxy-2-propylbenzoic acid Chemical compound CCCC1=C(O)C(O)=C(O)C=C1C(O)=O QULIOZDJZXKLNY-UHFFFAOYSA-N 0.000 description 1
- ZYIFAFPFZXUPAX-UHFFFAOYSA-N 3-(dimethylamino)propyl octadecanoate Chemical class CCCCCCCCCCCCCCCCCC(=O)OCCCN(C)C ZYIFAFPFZXUPAX-UHFFFAOYSA-N 0.000 description 1
- SDZHIRPZKXFSBX-UHFFFAOYSA-N 3-(dodecanoylamino)propanoic acid;zinc Chemical compound [Zn].CCCCCCCCCCCC(=O)NCCC(O)=O SDZHIRPZKXFSBX-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- YPIFGDQKSSMYHQ-UHFFFAOYSA-M 7,7-dimethyloctanoate Chemical compound CC(C)(C)CCCCCC([O-])=O YPIFGDQKSSMYHQ-UHFFFAOYSA-M 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- KUNFKKOYBPKDJE-UHFFFAOYSA-N C(C=1C(C(=O)O)=CC=CC1)(=O)O.C(C(C)O)O.OC(=O)CCCCCCCCC Chemical compound C(C=1C(C(=O)O)=CC=CC1)(=O)O.C(C(C)O)O.OC(=O)CCCCCCCCC KUNFKKOYBPKDJE-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- FTFSBTUNGWWUHI-UHFFFAOYSA-N CC(C(C(CO)(CO)CO)CC)(C)C Chemical compound CC(C(C(CO)(CO)CO)CC)(C)C FTFSBTUNGWWUHI-UHFFFAOYSA-N 0.000 description 1
- JIAVUMAJCIDZOU-UHFFFAOYSA-N CCCCCCCCCC(CCCCCC)OC(=O)CCCCCC(C)(C)C Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)CCCCCC(C)(C)C JIAVUMAJCIDZOU-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- PYVHTIWHNXTVPF-UHFFFAOYSA-N F.F.F.F.C=C Chemical compound F.F.F.F.C=C PYVHTIWHNXTVPF-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- OXPCWUWUWIWSGI-MSUUIHNZSA-N Lauryl oleate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC OXPCWUWUWIWSGI-MSUUIHNZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000581835 Monodora junodii Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- IOUVKUPGCMBWBT-DARKYYSBSA-N Phloridzin Natural products O[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-DARKYYSBSA-N 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- NKSOSPOXQKNIKJ-CLFAGFIQSA-N Polyoxyethylene dioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC\C=C/CCCCCCCC NKSOSPOXQKNIKJ-CLFAGFIQSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 244000223703 Syzygium aqueum Species 0.000 description 1
- 235000016572 Syzygium aqueum Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 1
- PRLUQOOFPFWUKQ-KKTNLPSRSA-N [(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] (z)-octadec-9-enoate Chemical compound C1C[C@@H]2[C@@]3(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C[C@@H]3CC[C@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@]21C PRLUQOOFPFWUKQ-KKTNLPSRSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- WUBKCBOQNXUQDU-UHFFFAOYSA-N [2-(dihydroxymethoxy)phenyl]-phenylmethanone Chemical compound OC(O)OC1=CC=CC=C1C(=O)C1=CC=CC=C1 WUBKCBOQNXUQDU-UHFFFAOYSA-N 0.000 description 1
- SVRHJWALMLOXMI-UHFFFAOYSA-N [2-(dihydroxymethoxy)phenyl]-phenylmethanone;sodium Chemical compound [Na].OC(O)OC1=CC=CC=C1C(=O)C1=CC=CC=C1 SVRHJWALMLOXMI-UHFFFAOYSA-N 0.000 description 1
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 1
- KSHPUQQHKKJVIO-UHFFFAOYSA-N [Na].[Zn] Chemical compound [Na].[Zn] KSHPUQQHKKJVIO-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DCAYPVUWAIABOU-UHFFFAOYSA-N alpha-n-hexadecene Natural products CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical class CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- VZWMKHUMEIECPK-UHFFFAOYSA-M benzyl-dimethyl-octadecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 VZWMKHUMEIECPK-UHFFFAOYSA-M 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical group CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- AGNCRIYGRWNVIF-UHFFFAOYSA-N calcium;2-(dodecanoylamino)acetic acid Chemical compound [Ca].CCCCCCCCCCCC(=O)NCC(O)=O AGNCRIYGRWNVIF-UHFFFAOYSA-N 0.000 description 1
- CEGYXKLZALIAEI-UHFFFAOYSA-N calcium;2-(dodecanoylamino)ethanesulfonic acid Chemical compound [Ca].CCCCCCCCCCCC(=O)NCCS(O)(=O)=O CEGYXKLZALIAEI-UHFFFAOYSA-N 0.000 description 1
- YEFORLIOCBRMFS-UHFFFAOYSA-N calcium;2-(hexadecanoylamino)ethanesulfonic acid Chemical compound [Ca].CCCCCCCCCCCCCCCC(=O)NCCS(O)(=O)=O YEFORLIOCBRMFS-UHFFFAOYSA-N 0.000 description 1
- HOQGRRFKKLWWOO-UHFFFAOYSA-N calcium;3-(dodecanoylamino)propanoic acid Chemical compound [Ca].CCCCCCCCCCCC(=O)NCCC(O)=O HOQGRRFKKLWWOO-UHFFFAOYSA-N 0.000 description 1
- HIAAVKYLDRCDFQ-UHFFFAOYSA-L calcium;dodecanoate Chemical compound [Ca+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O HIAAVKYLDRCDFQ-UHFFFAOYSA-L 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- 229940073724 cholesteryl isostearate Drugs 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- OFADGACXTNUQLM-UHFFFAOYSA-N decanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCC(O)=O.CCCCCCCCCC(O)=O OFADGACXTNUQLM-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- MIMDHDXOBDPUQW-UHFFFAOYSA-N dioctyl decanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC MIMDHDXOBDPUQW-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- FPMPNVIMFPEKRN-UHFFFAOYSA-N hexyl 16-methylheptadecanoate Chemical compound CCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C FPMPNVIMFPEKRN-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- PIUVNPNBPWVVKZ-UHFFFAOYSA-N octadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC PIUVNPNBPWVVKZ-UHFFFAOYSA-N 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- SFBIZPBTKROSDE-UHFFFAOYSA-N octyl 2-hydroxypropanoate Chemical compound CCCCCCCCOC(=O)C(C)O SFBIZPBTKROSDE-UHFFFAOYSA-N 0.000 description 1
- YPMOZWCBANATQH-UHFFFAOYSA-N octyl 7-methyloctanoate Chemical compound CCCCCCCCOC(=O)CCCCCC(C)C YPMOZWCBANATQH-UHFFFAOYSA-N 0.000 description 1
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 229940097156 peroxyl Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- LYKRPDCJKSXAHS-UHFFFAOYSA-N phenyl-(2,3,4,5-tetrahydroxyphenyl)methanone Chemical compound OC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1O LYKRPDCJKSXAHS-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-QNDFHXLGSA-N phlorizin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-QNDFHXLGSA-N 0.000 description 1
- 235000019139 phlorizin Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000010499 rapseed oil Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical class [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- YFGAFXCSLUUJRG-WCCKRBBISA-M sodium;(2s)-2-amino-5-(diaminomethylideneamino)pentanoate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCCN=C(N)N YFGAFXCSLUUJRG-WCCKRBBISA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- AGGIJOLULBJGTQ-UHFFFAOYSA-N sulfoacetic acid Chemical compound OC(=O)CS(O)(=O)=O AGGIJOLULBJGTQ-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000012184 tortilla Nutrition 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- APVVRLGIFCYZHJ-UHFFFAOYSA-N trioctyl 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCC)CC(=O)OCCCCCCCC APVVRLGIFCYZHJ-UHFFFAOYSA-N 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Medical Informatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 그린볼 사과 껍질추출물을 유효성분으로 포함하는 항산화용, 항염증용, 또는 주름개선용 약학적 조성물, 건강기능식품 조성물, 또는 화장료 조성물 등에 관한 것이다.The present invention relates to an antioxidant, anti-inflammatory, or anti-wrinkle pharmaceutical composition, health functional food composition, or cosmetic composition comprising the greenball apple peel extract as an active ingredient.
한국의 대표 과일 중 하나인 사과(Malus pumila Mill.)는 경제성장으로 소득 수준이 향상되면서 양적인 면보다는 질적인 면으로 소비 형태가 변화하고 있다. 흔히 ‘부사’라고 불리는 ‘후지’(Busa; Malus domestica Borkh.)는 가장 대표적인 사과 품종으로 2012년 기준 국내 과실 총 생산량의 29.5%를 점하고 있으며, 주로 대만에 수출되고 있다. 국내 사과는 당해에 약 50% 정도가 소비되고, 나머지는 저장되어 이듬해에 소비되는데, 저온 저장 후 수출되는 후지 사과는 품질 저하로 이듬해 2월부터는 수출이 매우 제한적으로 이루어지고 있다. 또한 일본 사과에 비해 인지도와 가격이 많이 떨어져서 아직까지 한국 사과는 품질이 중간 정도로 인식되고 있다. 그러나 2011년 일본의 원전 사고 이후 식품의 안전성에 대한 소비자의 우려가 커지면서 대만, 한국, 중국, 미국의 일본산 농식품 수입이 감소하였고, 2014년 4월 현재 37개국에서 일본산 농산물의 수입규제가 이행되고 있다. 중국의 경우, 일본 내에서 안전하다고 판단하는 지역의 농식품 수입도 전면 금지하는 엄격한 조치를 단행하고 있다. 이러한 일본의 원전사고 이후 농수산식품의 대외교역 변화를 기회로 한국산이 가지는 식품안전성과 가격경쟁력의 우위점을 활용하여 중국을 중심으로 다양한 국가로의 수출이 가능한 고품질 사과의 개발이 필요한 실정이었다.One of Korea's representative fruits, the apple ( Malus pumila Mill.) As the income level improves due to economic growth, the form of consumption is changing to quality rather than quantity. Busa; Malus , commonly called 'adverb' domestica Borkh.) is the most representative apple variety, accounting for 29.5% of the total domestic fruit production as of 2012, and is mainly exported to Taiwan. About 50% of domestic apples are consumed, and the rest are stored and consumed in the following year. Fuji apples, which are exported after low-temperature storage, have been limited in export since February of the following year due to deterioration in quality. In addition, recognition and prices are much lower than Japanese apples, so Korean apples are still regarded as medium in quality. However, as consumer concerns about food safety increased after the nuclear accident in Japan in 2011, imports of Japanese agri-food from Taiwan, Korea, China, and the United States declined. It is becoming. In China's case, strict measures have been taken to prohibit the importation of agri-food in areas considered safe in Japan. After the nuclear accident in Japan, it was necessary to develop high-quality apples that can be exported to various countries, especially in China, by taking advantage of Korean food safety and price competitiveness.
사과는 분류학상 장미과에 속하는 다년생 목본식물로서 유럽, 아시아 및 북아메리카의 북반구에서 재배된다. 민간에서 사과는 미용, 구토, 구충, 정혈, 변비 등에 약으로 쓰이고 있다. 사과의 종류중 하나인 능금은 소갈, 곽란, 복통 등을 다스리고 담을 없애며 이질을 다스린다. 덜 익은 능금은 맛은 떫으나 약으로 쓰인다. 그러나 많이 먹으면 잠이 많이 오며, 담이 생기고 종기가 난다. 사과를 발효시켜 만든 사과주는 독특한 풍미가 있으며, 특히 식후의 소화를 돕는 음료이다. 이런 사과주를 좀 더 산화 발효시켜 사과초를 만들어 화상에 바르면 즉시통증이 그친다고 향토의학에 나와 있고, 또 정맥류에 사과초를 환부에 밤낮으로 바르면 1개월 후에는 국소가 훨씬 작아진다고 한다. 사과는 이런 민간요법뿐 아니라 연구를 통해서도 그 효과를 증명하고 있다. 사과 과실은 관능특성이 좋고 영양학적으로 유기산과 당류와 같은 기호성 성분 이외에도 비타민, 미네랄, 칼륨, 나트륨 성분 및 폴리페놀 화합물과 같은 생리활성물질들을 함유하고 있다. 그 중에서 procyanidin, chlorogenic acid, caffeic acid, epicatechin, catechin, p-coumaroyl qunic acid, rutin, phloridzin, quercetin과 같은 다양한 폴리페놀 물질은 활성산소에 의한 생체 성분의 산화적 손상에 의하여 유발되는 피부노화, 비만, 염증, 동맥경화, 당뇨, 고혈압을 비롯하여 각종 암과 같은 퇴행성 질환의 예방에 효과가 있다고 알려져 있다(Yun HJ, Lim SY, Hur JM, Jeong JW, Yang SH, Kim DH. 2007. Korean J Food Preserv 14: 239-246.).Apples are a perennial herbaceous plant belonging to the taxonomic family Rosaceae, grown in the northern hemisphere of Europe, Asia, and North America. In the private world, apples are used for medicine, vomiting, hookworm, blood donation, and constipation. One type of apple, the tomb, manages beef, kwakran, abdominal pain, removes the wall, and controls dysentery. Unripe tortilla is tasteless but used as medicine. But if you eat a lot, you get a lot of sleep, you get a wall and you boil. Apple cider, made by fermenting apples, has a unique flavor, especially after digestion. If the cider is oxidized and fermented to make it more suitable for burns, local medicine says that the pain stops immediately, and if it is applied to the affected area day and night, the area is much smaller after one month. Apples have proven their effectiveness not only through folk remedies but also through research. Apple fruit is sensory and nutritious and contains bioactive substances such as vitamins, minerals, potassium, sodium and polyphenol compounds in addition to palates such as organic acids and sugars. Among them, various polyphenols such as procyanidin, chlorogenic acid, caffeic acid, epicatechin, catechin, p-coumaroyl qunic acid, rutin, phloridzin, quercetin are used for skin aging and obesity caused by oxidative damage of biological components by free radicals. It is known to be effective in preventing degenerative diseases such as inflammation, arteriosclerosis, diabetes, hypertension and various cancers (Yun HJ, Lim SY, Hur JM, Jeong JW, Yang SH, Kim DH. 2007. Korean J Food Preserv 14: 239-246.).
사과의 여러 가지 품종 중에서 그린볼(Green ball; Malus pumila Mill.) 사과는 국내에서 골든데리셔스(Golden delicious; 모본)와 후지(Fuji; 부본)을 이용하여 교배하여 육성한 신품종 사과로, 8월 하순에서 9월 상순에 익는 품종이고, 당도는 14°브릭스이며 과실 무게는 327g 정도이다. 그린볼 사과는 여름이 끝나는 시기에 맛볼 수 있는 녹황색 사과로 다 익은 상태에서도 녹색을 유지하며, 단맛과 신맛이 조화된 품종이다. 또한, 노동력이 적게 들고 기온이 상대적으로 높은 남부 지역에서도 재배 가능하다.Among the various varieties of apples, Green ball; Malus pumila Mill.) Apples are new varieties of apples grown in Korea using Golden Delicious (Fubon) and Fuji (Fubon), which are ripe from late August to early September. It is 14 ° brix and weighs about 327g. Greenball apples are green-yellow apples that can be tasted at the end of the summer. The greenball apples are green, ripe and sour. It can also be cultivated in the southern regions with less labor and relatively high temperatures.
한편, 생리활성 효과를 지닌 물질은 동식물에 널리 분포하고 있으며, 식물체는 자외선에 의한 산화나 자동산화, 곤충들로 인한 피해로부터 자신을 보호하기 위하여 polyphenol류의 항산화 물질을 세포 내 함유하며, flavonoid류와 산성의 phenolic compounds는 항산화, 항알러지, 항당뇨, 항암, 항염증, 미백, 주름개선 등 다양한 생리활성을 지닌 것으로 알려져 있다. 최근에는 효능이 검증된 약용식물자원 유래의 생리활성과 우수한 기능성 물질에 대한 기능성식품 및 기능성 화장품 분야에서 많은 연구와 개발이 이루어지고 있으며, 약용식물이나 산채류, 한약재, 과실류 등 약용부위의 물질을 탐색하여 건강기능성 식품이나 식품부재료로 개발하는 것은 천연자원의 효율적인 이용 측면과 새로운 식품자원 개발, 신소재 개발에 기여할 수 있다는 측면에서도 매우 의미 있는 일이라 할 수 있다.On the other hand, biologically active substances are widely distributed in animals and plants, and plants contain polyphenol-based antioxidant substances in cells to protect themselves from oxidative oxidation, automatic oxidation and damage caused by insects, and flavonoids. Acidic phenolic compounds are known to have various physiological activities such as antioxidant, anti-allergy, anti-diabetic, anti-cancer, anti-inflammatory, whitening, wrinkle improvement. Recently, many researches and developments have been made in the fields of functional foods and functional cosmetics for the physiological activity and excellent functional substances derived from medicinal plant resources, which have been proven effective, and search for substances in medicinal parts such as medicinal plants, wild vegetables, herbal medicines and fruits. Therefore, the development of health functional food or food supplementary materials is very meaningful in terms of efficient use of natural resources, new food resources development, and new materials development.
이에, 본 발명자들은 국내에서 육종한 신품종인 상기 그린볼 품종의 사과에 대한 항산화, 항염증, 및 주름개선 등의 효과 분석을 통해 고부가가치 기능성소재로서의 개발을 시도하였다.Thus, the present inventors attempted to develop a high value-added functional material by analyzing the effects of antioxidant, anti-inflammatory, and wrinkle improvement on the apples of the greenball variety, a new breed bred in Korea.
본 발명자들은 국내에서 육종한 신품종인 그린볼 품종의 사과가 부사 품종에 비해 항산화, 항염증, 및 주름개선 효과가 뛰어남을 확인하였고, 특히 그린볼 사과의 껍질추출물에서 효과가 가장 현저함을 발견하였다.The present inventors confirmed that the apples of the new breed of greenball varieties bred in Korea had better antioxidant, anti-inflammatory, and anti-wrinkle effects than the adverb varieties, and found that the effect was the most remarkable in the peel extract of greenball apples. .
이에, 본 발명의 목적은 그린볼 사과 껍질추출물을 유효성분으로 포함하는 항산화, 항염증, 또는 주름개선용 약학적 조성물, 건강기능식품 조성물, 또는 화장료 조성물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide an antioxidant, anti-inflammatory, or anti-wrinkle pharmaceutical composition, health functional food composition, or cosmetic composition comprising the greenball apple peel extract as an active ingredient.
그러나 본 발명이 이루고자 하는 기술적 과제는 이상에서 언급한 과제에 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당해 기술분야의 통상의 기술자에게 명확하게 이해될 수 있을 것이다.However, the technical problem to be achieved by the present invention is not limited to the above-mentioned problem, another task not mentioned will be clearly understood by those skilled in the art from the following description.
상기와 같은 목적을 달성하기 위하여, 본 발명은 그린볼(green ball) 사과 껍질추출물을 유효성분으로 포함하는 항산화용; 항염증용; 또는 주름개선용 약학적 조성물을 제공한다.In order to achieve the above object, the present invention is an antioxidant for containing a green ball apple peel extract as an active ingredient; Anti-inflammatory; Or it provides a pharmaceutical composition for wrinkle improvement.
또한, 본 발명은 그린볼(green ball) 사과 껍질추출물을 유효성분으로 포함하는 항산화용; 항염증용; 또는 주름개선용 건강기능식품 조성물을 제공한다.In addition, the present invention for the antioxidant containing a green ball apple peel extract as an active ingredient; Anti-inflammatory; Or it provides a functional food composition for improving wrinkles.
또한, 본 발명은 그린볼(green ball) 사과 껍질추출물을 유효성분으로 포함하는 항산화용; 항염증용; 또는 주름개선용 화장료 조성물을 제공한다.In addition, the present invention for the antioxidant containing a green ball apple peel extract as an active ingredient; Anti-inflammatory; Or to provide a cosmetic composition for improving wrinkles.
본 발명의 일구현예로, 상기 조성물은 1,1-디페닐-2-피크릴하이드라질(1,1-diphenyl-2-picrylhydrazyl; DPPH) 라디칼 저해, 2,2'-아지노비스-(3-에틸벤조티아졸린-6-설폰산)(2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid; ABTS) 라디칼 저해, 티오바르비튜릭산 반응성 물질(Thiobarbituric acid reactive substances; TBARs) 저해 또는 항산화물질 보호 인자(Antioxidant protection factor; PF)를 증가시킬 수 있다.In one embodiment of the invention, the composition is 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical inhibition, 2,2'-azinobis- (3 Inhibition of 2,2'-Azinobis- (3-ethylbenzothiazoline-6-sulfonic acid; ABTS) radicals, inhibition of Thiobarbituric acid reactive substances (TBARs), or It can increase the antioxidant protection factor (PF).
본 발명의 다른 구현예로, 상기 조성물은 히알루로니다아제(hyaluronidase)를 저해할 수 있다.In another embodiment of the present invention, the composition may inhibit hyaluronidase.
본 발명의 또 다른 구현예로, 상기 조성물은 엘라스타아제(elastase) 또는 콜라게나아제(collagenase)를 저해할 수 있다.In another embodiment of the present invention, the composition may inhibit elastase or collagenase.
본 발명의 또 다른 구현예로, 상기 그린볼 사과 껍질추출물은 물, C1내지 C4의 저급알코올, n-헥산, 에틸아세테이트, 아세톤, 부틸아세테이트, 1,3-부틸렌 글리콜, 메틸렌클로라이드, 및 이들의 혼합용매로 구성된 군으로부터 선택된 용매로 추출될 수 있다.In another embodiment of the present invention, the greenball apple peel extract is water, C 1 to C 4 lower alcohol, n-hexane, ethyl acetate, acetone, butyl acetate, 1,3-butylene glycol, methylene chloride, And it may be extracted with a solvent selected from the group consisting of mixed solvents thereof.
또한, 본 발명은 상기 약학적 조성물을 개체에 투여하는 단계를 포함하는 항산화; 항염증; 또는 주름개선 방법을 제공한다.In addition, the present invention provides an antioxidant comprising administering the pharmaceutical composition to a subject; Anti-inflammatory; Or it provides a wrinkle improvement method.
또한, 본 발명은 상기 약학적 조성물의 항산화; 항염증; 또는 주름개선 용도를 제공한다.In addition, the present invention provides antioxidants of the pharmaceutical composition; Anti-inflammatory; Or anti-wrinkle applications.
본 발명의 신육성 품종인 그린볼(Green ball; Malus pumila Mill.) 사과 껍질추출물은 DPPH radical, ABTS radical, 및 TBARs를 저해하고 PF를 증가시킴으로써 항산화 효과를 가지며, hyaluronidase 활성을 저해함으로써 염증반응을 억제시키는 효과를 나타낸다. 또한, elastase 활성을 저해함으로써 elastin 분자 형태를 유지시키고, collagenase 활성을 저해함으로써 주름개선 효과를 나타낸다.Green ball (Malus pumila Mill.) Apple peel extract of the new breed of the present invention has an antioxidant effect by inhibiting DPPH radicals, ABTS radicals, and TBARs and increasing PF, and inhibits hyaluronidase activity to inflame the inflammatory response. It shows an inhibitory effect. In addition, it inhibits elastase activity and maintains elastin molecular form, and inhibits collagenase activity, thereby showing an anti-wrinkle effect.
따라서, 본 발명에 따른 그린볼 사과 껍질추출물은 항산화, 항염증, 또는 주름개선용 약학적 조성물, 건강기능식품 조성물, 및 화장료 조성물 등으로 유용하게 이용될 수 있을 것으로 기대된다.Therefore, the greenball apple peel extract according to the present invention is expected to be useful as an antioxidant, anti-inflammatory, or anti-wrinkle pharmaceutical composition, health food composition, and cosmetic composition.
도 1은 본 발명의 일구현예에 따른 그린볼 사과의 껍질(peel) 및 whole 사과의 물 및 에탄올 추출물에서의 phenolic 함량을 나타낸 도면이다.
도 2는 본 발명의 일구현예에 따른 그린볼 사과의 껍질 및 whole 사과 추출물에서 collagenase 저해 효과를 나타낸 도면이다.
도 3a는 본 발명의 일구현예에 따른 그린볼 사과 껍질의 고형분과 phenolic 성분의 생리활성 비교를 위해 각각의 DPPH radical 소거능을 용매별(water, ethanol)로 측정한 결과를 나타낸 도면이다.
도 3b는 본 발명의 일구현예에 따른 그린볼 whole 사과의 고형분과 phenolic 성분의 생리활성 비교를 위해 각각의 DPPH radical 소거능을 용매별(water, ethanol)로 측정한 결과를 나타낸 도면이다.
도 3c는 본 발명의 일구현예에 따른 그린볼 사과 껍질의 고형분과 phenolic 성분의 생리활성 비교를 위해 각각의 ABTS radical 소거능을 용매별(water, ethanol)로 측정한 결과를 나타낸 도면이다.
도 3d는 본 발명의 일구현예에 따른 그린볼 whole 사과의 고형분과 phenolic 성분의 생리활성 비교를 위해 각각의 ABTS radical 소거능을 용매별(water, ethanol)로 측정한 결과를 나타낸 도면이다.
도 4a는 본 발명의 일구현예에 따른 그린볼 사과 껍질의 용매 종류별 추출물에서 phenolic 함량을 나타낸 도면이다.
도 4b는 본 발명의 일구현예에 따른 그린볼 사과 껍질의 에탄올 농도별 추출물에서 phenolic 함량을 나타낸 도면이다.
도 4c는 본 발명의 일구현예에 따른 그린볼 whole 사과의 에탄올 농도별 추출물에서 phenolic 함량을 나타낸 도면이다.
도 5는 본 발명의 일구현예에 따른 그린볼 사과 껍질 및 부사 사과 껍질의 물 및 에탄올 추출물에서 phenolic 농도별 DPPH radical 소거능을 측정한 결과를 나타낸 도면이다.
도 6은 본 발명의 일구현예에 따른 그린볼 사과 껍질 및 부사 사과 껍질의 물 및 에탄올 추출물에서 phenolic 농도별 ABTS radical 소거능을 측정한 결과를 나타낸 도면이다.
도 7은 본 발명의 일구현예에 따른 그린볼 사과 껍질 및 부사 사과 껍질의 물 및 에탄올 추출물에서 phenolic 농도별 PF를 측정한 결과를 나타낸 도면이다.
도 8은 본 발명의 일구현예에 따른 그린볼 사과 껍질 및 부사 사과 껍질의 물 및 에탄올 추출물에서 phenolic 농도별 TBARs 저해 효과를 나타낸 도면이다.
도 9는 본 발명의 일구현예에 따른 그린볼 사과 껍질 및 부사 사과 껍질의 물 및 에탄올 추출물에서 phenolic 농도별 hyaluronidase 저해 효과를 나타낸 도면이다.
도 10a는 본 발명의 일구현예에 따른 그린볼 사과 껍질 및 부사 사과 껍질의 물 및 에탄올 추출물에서 phenolic 농도별 elastase 저해 효과를 나타낸 도면이다.
도 10b는 본 발명의 일구현예에 따른 그린볼 사과 껍질 및 부사 사과 껍질의 물 및 에탄올 추출물에서 phenolic 농도별 collagenase 저해 효과를 나타낸 도면이다.1 is a view showing the phenolic content in the water and ethanol extract of the peel (peel) and whole apple of the greenball apple according to an embodiment of the present invention.
Figure 2 is a view showing the collagenase inhibitory effect in the peel and whole apple extract of the greenball apple according to an embodiment of the present invention.
Figure 3a is a view showing the results of measuring the DPPH radical scavenging ability by solvent (water, ethanol) for comparing the physiological activity of the solid and phenolic components of the greenball apple peel according to an embodiment of the present invention.
Figure 3b is a view showing the results of measuring the DPPH radical scavenging ability by solvent (water, ethanol) to compare the physiological activity of the solid and phenolic components of the green ball whole apple according to an embodiment of the present invention.
Figure 3c is a view showing the results of measuring the respective ABTS radical scavenging ability by solvent (water, ethanol) for comparing the physiological activity of the solid content and phenolic components of the greenball apple peel according to an embodiment of the present invention.
3d is a view showing the results of measuring the ABTS radical scavenging ability by solvent (water, ethanol) for comparing the physiological activity of the solid content and phenolic components of the green ball whole apple according to an embodiment of the present invention.
Figure 4a is a view showing the phenolic content in the solvent-specific extracts of the greenball apple peel according to an embodiment of the present invention.
Figure 4b is a view showing the phenolic content in the extract of ethanol concentration of greenball apple peel according to an embodiment of the present invention.
Figure 4c is a view showing the phenolic content in the ethanol concentration extract of greenball whole apples according to an embodiment of the present invention.
5 is a view showing the results of measuring DPPH radical scavenging ability according to phenolic concentrations in water and ethanol extracts of greenball apple peel and adverb apple peel according to one embodiment of the present invention.
6 is a view showing the results of measuring the ABTS radical scavenging ability according to the phenolic concentration in the water and ethanol extract of the greenball apple peel and the adverb apple peel according to an embodiment of the present invention.
7 is a view showing the results of measuring the PF by phenolic concentration in the water and ethanol extract of the greenball apple peel and adverb apple peel in accordance with an embodiment of the present invention.
8 is a view showing the TBARs inhibitory effect according to phenolic concentrations in water and ethanol extracts of greenball apple peel and adverb apple peel according to an embodiment of the present invention.
9 is a view showing the hyaluronidase inhibitory effect of phenolic concentrations in water and ethanol extracts of greenball apple peel and adverb apple peel according to one embodiment of the present invention.
Figure 10a is a view showing the elastase inhibitory effect of phenolic concentrations in water and ethanol extracts of greenball apple peel and adverb apple peel according to an embodiment of the present invention.
Figure 10b is a view showing the collagenase inhibitory effect according to phenolic concentration in water and ethanol extracts of greenball apple peel and adverb apple peel according to an embodiment of the present invention.
본 발명은 다양한 변환을 가할 수 있고 여러 가지 실시예를 가질 수 있는 바, 특정 실시예들을 도면에 예시하고 상세한 설명에 상세하게 설명하고자 한다. 그러나, 이는 본 발명을 특정한 실시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변환, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. 본 발명을 설명함에 있어서 관련된 공지 기술에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우 그 상세한 설명을 생략한다.As the invention allows for various changes and numerous embodiments, particular embodiments will be illustrated in the drawings and described in detail in the written description. However, this is not intended to limit the present invention to specific embodiments, it should be understood to include all transformations, equivalents, and substitutes included in the spirit and scope of the present invention. In the following description of the present invention, if it is determined that the detailed description of the related known technology may obscure the gist of the present invention, the detailed description thereof will be omitted.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 그린볼 사과 껍질추출물을 유효성분으로 포함하는 항산화용; 항염증용; 또는 주름개선용 약학적 조성물을 제공한다.The present invention for antioxidant comprising a greenball apple peel extract as an active ingredient; Anti-inflammatory; Or it provides a pharmaceutical composition for wrinkle improvement.
본 발명에서 "추출물"은, 상기 그린볼 사과 껍질의 추출처리에 의하여 얻어지는 추출액, 상기 추출액의 희석액이나 농축액, 상기 추출액을 건조하여 얻어지는 건조물, 상기 추출액의 조정제물이나 정제물, 또는 이들의 혼합물 등, 추출액 자체 및 추출액을 이용하여 형성 가능한 모든 제형의 추출물을 포함한다.In the present invention, an "extract" is an extract obtained by the extraction process of the greenball apple peel, a diluent or concentrate of the extract, a dried product obtained by drying the extract, a crude or purified product of the extract, a mixture thereof, and the like. , Extracts themselves and extracts of all formulations that can be formed using the extracts.
본 발명의 상기 그린볼 사과 껍질추출물에 있어서, 상기 그린볼 사과 껍질을 추출하는 방법은 특별히 제한되지 아니하며, 당해 기술분야에서 통상적으로 사용하는 방법에 따라 추출할 수 있다. 상기 추출 방법의 비제한적인 예로는, 열수 추출법, 초음파 추출법, 여과법, 환류 추출법 등을 들 수 있으며, 이들은 단독으로 수행되거나 2 종 이상의 방법을 병용하여 수행될 수 있다. In the greenball apple peel extract of the present invention, the method of extracting the greenball apple peel is not particularly limited and may be extracted according to a method commonly used in the art. Non-limiting examples of the extraction method, hot water extraction method, ultrasonic extraction method, filtration method, reflux extraction method and the like, these may be performed alone or in combination of two or more methods.
본 발명에서 상기 그린볼 사과 껍질을 추출하는 데에 사용되는 추출 용매의 종류는 특별히 제한되지 아니하며, 천연물로부터 추출물을 추출하는 당업계에 공지된 통상적인 방법에 따라, 즉, 통상적인 온도, 압력의 조건 하에서 통상적인 용매를 사용하여 추출할 수 있다. 예컨대, 본 발명에서 그린볼 사과 껍질추출물은 물, 탄소 수 1 내지 4의 저급 알코올, n-헥산, 에틸아세테이트, 아세톤, 부틸아세테이트, 1,3-부틸렌 글리콜, 메틸렌클로라이드, 및 이들의 혼합 용매로 이루어진 군으로부터 선택된 1종 이상의 용매를 사용하여 추출할 수 있으며, 본 발명의 일 구현예에 따르면 물 또는 에탄올을 사용하여 추출할 수 있으나, 이에 제한되지 않는다.The kind of the extraction solvent used to extract the greenball apple peel in the present invention is not particularly limited, and according to a conventional method known in the art for extracting the extract from natural products, that is, the conventional temperature, pressure Extraction can be carried out using conventional solvents under conditions. For example, the greenball apple peel extract in the present invention is water, lower alcohol having 1 to 4 carbon atoms, n-hexane, ethyl acetate, acetone, butyl acetate, 1,3-butylene glycol, methylene chloride, and a mixed solvent thereof Can be extracted using one or more solvents selected from the group consisting of, according to one embodiment of the present invention can be extracted using water or ethanol, but is not limited thereto.
상기 제조된 추출물은 이후 여과하거나 농축 또는 건조과정을 수행하여 용매를 제거할 수 있으며, 여과, 농축 및 건조를 모두 수행할 수 있다. 예컨대, 여과는 여과지를 이용하거나 감압여과기를 이용할 수 있으며, 농축은 감압 농축기, 건조는 동결건조법 등을 수행할 수 있으나, 이에 제한되는 것은 아니다.The prepared extract may then be filtered or concentrated or dried to remove the solvent, it can be carried out both filtration, concentration and drying. For example, the filtration may use a filter paper or a vacuum filter, the concentration may be a vacuum concentrator, the drying may be a freeze-drying method, but is not limited thereto.
또한, 본 발명은 상기 약학적 조성물을 개체에 투여하는 단계를 포함하는 항산화; 항염증; 또는 주름개선 방법을 제공한다.In addition, the present invention provides an antioxidant comprising administering the pharmaceutical composition to a subject; Anti-inflammatory; Or it provides a wrinkle improvement method.
본 발명에서 사용되는 용어 "투여"는 임의의 적절한 방법으로 개체에게 소정의 본 발명의 조성물을 제공하는 것을 의미한다.As used herein, the term "administration" means providing a subject with any composition of the present invention in any suitable manner.
본 발명에서 사용되는 용어 "개체"란 항산화, 항염증, 또는 주름개선을 필요로 하는 대상을 의미하고, 보다 구체적으로는, 인간 또는 비-인간인 영장류, 생쥐(mouse), 개, 고양이, 말, 및 소 등의 포유류를 의미한다.As used herein, the term "individual" refers to a subject in need of antioxidant, anti-inflammatory, or anti-wrinkle, and more specifically, human or non-human primates, mice, dogs, cats, horses And mammals such as cows.
또한, 본 발명은 상기 약학적 조성물의 항산화; 항염증; 또는 주름개선 용도를 제공한다.In addition, the present invention provides antioxidants of the pharmaceutical composition; Anti-inflammatory; Or anti-wrinkle applications.
본 발명에서 "약학적 조성물"은 항산화, 항염증, 또는 주름개선을 목적으로 제조된 것을 의미하며, 각각 통상의 방법에 따라 다양한 형태로 제형화하여 사용될 수 있다. 예컨대, 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽 등의 경구형 제형으로 제형화할 수 있고, 크림, 젤, 패취, 분무제, 연고제, 경고제, 로션제, 리니멘트제, 파스타제 또는 카타플라스마제 등의 외용제, 좌제 및 멸균 주사용액의 형태로 제형화하여 사용할 수 있다.In the present invention, the "pharmaceutical composition" means that it is prepared for the purpose of antioxidant, anti-inflammatory, or wrinkle improvement, each can be used in formulated in various forms according to conventional methods. For example, they may be formulated in oral dosage forms such as powders, granules, tablets, capsules, suspensions, emulsions, syrups, and the like, creams, gels, patches, sprays, ointments, warnings, lotions, liniments, pasta or It may be formulated in the form of external preparations such as cataplasma, suppositories, and sterile injectable solutions.
본 발명에 따른 약학적 조성물은 약학적 조성물의 제조에 통상적으로 사용하는 적절한 담체, 부형제 및 희석제를 더 포함할 수 있다. 이 때, 조성물에 포함될 수 있는 담체, 부형제 및 희석제로는 락토즈, 덱스트로즈, 수크로스, 올리고당, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸 셀룰로즈, 미정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유를 들 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 추출물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트(calcium carbonate), 수크로스(sucrose) 또는 락토오스(lactose), 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스티레이트 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조제제, 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜 (propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈 (tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다.The pharmaceutical compositions according to the invention may further comprise suitable carriers, excipients and diluents conventionally used in the preparation of pharmaceutical compositions. At this time, carriers, excipients and diluents that may be included in the composition include lactose, dextrose, sucrose, oligosaccharide, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium Silicates, cellulose, methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. When formulated, diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents and surfactants are usually used. Solid preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, and such solid preparations may include at least one excipient such as starch, calcium carbonate, sucrose in the extract. Or lactose, gelatin and the like. In addition to simple excipients, lubricants such as magnesium styrate talc are also used. Oral liquid preparations include suspensions, solvents, emulsions, and syrups, and may include various excipients, such as wetting agents, sweeteners, fragrances, and preservatives, in addition to commonly used simple diluents such as water and liquid paraffin. . Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations, suppositories. As the non-aqueous solvent and suspending agent, propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate and the like can be used. As the base of the suppository, witepsol, macrogol, tween 61, cacao butter, laurin butter, glycerogelatin and the like can be used.
본 발명의 약학적 조성물은 목적하는 방법에 따라 경구 투여하거나 비경구투여(예를 들어, 정맥 내, 피하, 복강 내 또는 국소에 적용)할 수 있으며, 투여량은 환자의 상태 및 체중, 질병의 정도, 약물형태, 투여경로 및 시간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다.The pharmaceutical compositions of the invention may be administered orally or parenterally (eg, applied intravenously, subcutaneously, intraperitoneally or topically) according to the desired method, and the dosage may be determined by the condition and weight of the patient, Depending on the degree, drug form, route of administration, and time, it may be appropriately selected by those skilled in the art.
본 발명의 약학적 조성물은 약학적으로 유효한 양으로 투여한다. 본 발명에 있어서 "약학적으로 유효한 양"은 의학적 치료에 적용 가능한 합리적인 수혜/위험 비율로 질환을 치료하기에 충분한 양을 의미하며, 유효용량 수준은 환자의 질환의 종류, 중증도, 약물의 활성, 약물에 대한 민감도, 투여 시간, 투여 경로 및 배출비율, 치료기간, 동시 사용되는 약물을 포함한 요소 및 기타 의학 분야에 잘 알려진 요소에 따라 결정될 수 있다. 본 발명에 따른 약학적 조성물은 개별 치료제로 투여하거나 다른 치료제와 병용하여 투여될 수 있고 종래의 치료제와는 순차적 또는 동시에 투여될 수 있으며, 단일 또는 다중 투여될 수 있다. 상기 요소들을 모두 고려하여 부작용 없이 최소한의 양으로 최대 효과를 얻을 수 있는 양을 투여하는 것이 중요하며, 이는 당업자에 의해 용이하게 결정될 수 있다. 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수도 있다. The pharmaceutical composition of the present invention is administered in a pharmaceutically effective amount. As used herein, the term “pharmaceutically effective amount” means an amount sufficient to treat a disease at a reasonable benefit / risk ratio applicable to medical treatment, and the effective dose level refers to the type of disease, severity, activity of the drug, It may be determined according to the sensitivity to the drug, the time of administration, the route of administration and the rate of release, the duration of treatment, factors including the drug used concurrently and other factors well known in the medical field. The pharmaceutical compositions according to the present invention may be administered as individual therapeutic agents or in combination with other therapeutic agents, may be administered sequentially or simultaneously with conventional therapeutic agents, and may be single or multiple doses. Taking all of the above factors into consideration, it is important to administer an amount that can achieve the maximum effect with a minimum amount without side effects, which can be readily determined by one skilled in the art. Administration may be administered once a day or may be divided several times.
또한, 본 발명은 그린볼(green ball) 사과 껍질추출물을 유효성분으로 포함하는 항산화용; 항염증용; 또는 주름개선용 건강기능식품 조성물을 제공한다.In addition, the present invention for the antioxidant containing a green ball apple peel extract as an active ingredient; Anti-inflammatory; Or it provides a functional food composition for improving wrinkles.
본 발명에서 사용되는 용어 “개선”은, 치료되는 상태와 관련된 파라미터, 예를 들면 증상의 정도를 적어도 감소시키는 모든 행위를 의미한다.As used herein, the term “improvement” means any action that at least reduces the parameters associated with the condition being treated, for example the extent of symptoms.
본 발명에서 "건강기능식품 조성물"은, 담체, 희석제, 부형제 및 첨가제 중 하나 이상을 포함하여 정제, 환제, 산제, 과립제, 분말제, 캡슐제 및 액제 제형으로 이루어진 군에서 선택된 하나로 제형된 것을 특징으로 한다. In the present invention, the "health food composition" is characterized in that it is formulated as one selected from the group consisting of tablets, pills, powders, granules, powders, capsules and liquid formulations, including one or more of carriers, diluents, excipients and additives. It is done.
본 발명의 그린볼 사과 껍질추출물에 첨가할 수 있는 식품으로는, 각종 식품류, 분말, 과립, 정제, 캡슐, 시럽제, 음료, 껌, 차, 비타민 복합제, 건강 기능성 식품류 등이 있다. 상기 본 발명에 더 포함될 수 있는 첨가제로는, 천연 탄수화물, 향미제, 영양제, 비타민, 광물(전해질), 풍미제(합성 풍미제, 천연 풍미제 등), 착색제, 충진제, 팩트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH조절제, 안정화제, 방부제, 산화 방지제, 글리세린, 알코올, 탄산화제, 및 과육으로 이루어진 군으로부터 선택된 1종 이상의 성분을 사용할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토오스, 수크로오스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알코올이다. 상기 향미제로서 천연 향미제(타우마틴, 스테비아추출물(예를 들어 레바우디오시드 A, 글리시르히진 등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. Foods that can be added to the greenball apple peel extract of the present invention include various foods, powders, granules, tablets, capsules, syrups, beverages, gums, teas, vitamin complexes, and health functional foods. As additives that may be further included in the present invention, natural carbohydrates, flavoring agents, nutrients, vitamins, minerals (electrolytes), flavoring agents (synthetic flavoring agents, natural flavoring agents, etc.), colorants, fillers, pactic acid and salts thereof, Alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusting agents, stabilizers, preservatives, antioxidants, glycerin, alcohols, carbonation agents, and one or more components selected from the group consisting of pulp can be used. Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And conventional sugars such as polysaccharides such as dextrin, cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the flavoring agent, natural flavoring agents (tauumatin, stevia extract (for example, rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used.
상기 외에 본 발명에 따른 조성물은 여러 가지 영양제, 비타민, 광물 (전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제, 팩트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. In addition to the above, the composition according to the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents, fact acids and salts thereof, alginic acid and salts thereof, organic acids, protection Sex colloid thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages and the like.
그밖에 본 발명에 따른 조성물은 천연 과일 주스 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. In addition, the compositions according to the invention may contain flesh for the production of natural fruit juices and vegetable beverages. These components can be used independently or in combination.
상기 담체, 부형제, 희석제 및 첨가제의 구체적인 예로는 이에 한정하는 것은 아니나, 락토오스, 덱스트로즈, 수크로오스, 솔비톨, 만니톨, 에리스리톨, 전분, 아카시아 고무, 인산칼슘, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 미세결정성 셀룰로오스, 폴리비닐키롤리돈, 셀룰로오스, 폴리비닐피로리돈, 메틸셀룰로오스, 물, 설탕시럽, 메틸 하이드록시 벤조에이트, 프로필하이드록시 벤조에이트, 활석, 스테아르산 마그네슘, 및 미네랄 오일로 이루어진 그룹으로부터 선택된 1종 이상이 사용되는 것이 바람직하다.Specific examples of the carrier, excipient, diluent and additives include, but are not limited to, lactose, dextrose, sucrose, sorbitol, mannitol, erythritol, starch, acacia rubber, calcium phosphate, alginate, gelatin, calcium phosphate, calcium silicate, Group consisting of microcrystalline cellulose, polyvinylchirrolidone, cellulose, polyvinylpyrrolidone, methylcellulose, water, sugar syrup, methyl hydroxy benzoate, propylhydroxy benzoate, talc, magnesium stearate, and mineral oil It is preferred that at least one selected from be used.
또한, 본 발명은 그린볼(green ball) 사과 껍질추출물을 유효성분으로 포함하는 항산화용; 항염증용; 또는 주름개선용 화장료 조성물을 제공한다.In addition, the present invention for the antioxidant containing a green ball apple peel extract as an active ingredient; Anti-inflammatory; Or to provide a cosmetic composition for improving wrinkles.
본 발명의 그린볼 사과 껍질추출물을 포함하는 화장료 조성물은 피부의 항산화, 염증억제, 주름개선 효과를 위한 화장품 및 세안제 등에 다양하게 이용될 수 있다. 본 조성물을 첨가할 수 있는 제품으로는, 예를 들어, 각종 크림, 로션, 스킨 등과 같은 화장품류와 클렌징, 세안제, 비누, 트리트먼트, 미용액 등이 있다.Cosmetic composition comprising the greenball apple peel extract of the present invention can be used in a variety of cosmetics and cleansing agents for the skin's antioxidant, anti-inflammatory, anti-wrinkle effect. Examples of products to which the present composition can be added include cosmetics such as various creams, lotions, skins, and the like, cleansing agents, face washes, soaps, treatments, and essences.
본 발명의 화장료는 수용성 비타민, 유용성 비타민, 고분자 펩티드, 고분자 다당, 스핑고 지질 및 해초 엑기스로 이루어진 군에서 선택된 조성물을 포함한다.The cosmetic of the present invention comprises a composition selected from the group consisting of water soluble vitamins, oil soluble vitamins, polymer peptides, polymer polysaccharides, sphingolipids and seaweed extracts.
수용성 비타민으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 비타민 B1, 비타민 B2, 비타민 B6, 피리독신, 염산피리독신, 비타민 B12, 판토텐산, 니코틴산, 니코틴산아미드, 엽산, 비타민 C, 비타민 H 등을 들 수 있으며, 그들의 염 (티아민염산염, 아스코르빈산나트륨염 등)이나 유도체 (아스코르빈산-2-인산나트륨염, 아스코르빈산-2-인산마그네슘염 등)도 본 발명에서 사용할 수 있는 수용성 비타민에 포함된다. 수용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 수득할 수 있다.The water-soluble vitamin may be any compound that can be incorporated into cosmetics, but preferably vitamin B1, vitamin B2, vitamin B6, pyridoxine, pyridoxine, vitamin B12, pantothenic acid, nicotinic acid, nicotinic acid amide, folic acid, vitamin C, vitamin H, and the like. Their salts (thiamine hydrochloride, sodium ascorbate salt, etc.) and derivatives (ascorbic acid-2-sodium phosphate salt, ascorbic acid-2-magnesium phosphate salt, etc.) may also be used in the water-soluble vitamins usable in the present invention. Included. The water-soluble vitamin can be obtained by conventional methods such as microbial transformation, purification from culture of microorganisms, enzymatic or chemical synthesis.
유용성 비타민으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 비타민 A, 카로틴, 비타민 D2, 비타민 D3, 비타민 E (d1-알파 토코페롤, d-알파 토코페롤, d-알파 토코페롤) 등을 들 수 있으며, 그들의 유도체 (팔미틴산아스코르빈, 스테아르산아스코르빈, 디팔미틴산아스코르빈, 아세트산dl-알파 토코페롤, 니코틴산dl-알파 토코페롤비타민 E, DL-판토테닐알코올, D-판토테닐알코올, 판토테닐에틸에테르 등) 등도 본 발명에서 사용되는 유용성 비타민에 포함된다. 유용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소 또는 화학 합성법 등의 통상의 방법에 의해 취득할 수 있다.The oil-soluble vitamin may be any compound that can be incorporated into cosmetics, but preferably vitamin A, carotene, vitamin D2, vitamin D3, vitamin E (d1-alpha tocopherol, d-alpha tocopherol, d-alpha tocopherol), and the like. , Derivatives thereof (ascorbic palmitate, ascorbic stearate, ascorbic acid dipalmitate, dl-alpha tocopherol acetate, dl-alpha tocopherolvitamin E, DL-pantothenyl alcohol, D-pantothenyl alcohol, pantothenyl ethyl) Ethers, etc.) are also included in the oil-soluble vitamins used in the present invention. Oil-soluble vitamins can be obtained by conventional methods such as microbial transformation, purification of microorganism culture, enzyme or chemical synthesis.
고분자 펩티드로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 콜라겐, 가수 분해 콜라겐, 젤라틴, 엘라스틴, 가수 분해 엘라스틴, 케라틴 등을 들 수 있다. 고분자 펩티드는 미생물의 배양액으로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 정제 취득할 수 있으며, 또는 통상 돼지나 소 등의 진피, 누에의 견섬유 등의 천연물로부터 정제하여 사용할 수 있다.The polymer peptide may be any compound as long as it can be incorporated into cosmetics. Preferably, collagen, hydrolyzed collagen, gelatin, elastin, hydrolyzed elastin, keratin and the like can be given. Polymeric peptides can be purified and obtained by conventional methods such as purification from microbial cultures, enzymatic methods or chemical synthesis methods, or can be purified and used from natural products such as dermis and pig silk such as pigs and cattle.
고분자 다당으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 히드록시에틸셀룰로오스, 크산탄검, 히알루론산나트륨, 콘드로이틴 황산 또는 그 염 (나트륨염 등) 등을 들 수 있다. 예를 들어, 콘드로이틴 황산 또는 그 염 등은 통상 포유 동물이나 어류로부터 정제하여 사용할 수 있다.The polymer polysaccharide may be any compound as long as it can be blended into cosmetics. Preferably, hydroxyethyl cellulose, xanthan gum, sodium hyaluronate, chondroitin sulfate or a salt thereof (sodium salt, etc.) may be mentioned. For example, chondroitin sulfate or its salt, etc. can be normally purified from a mammal or a fish.
스핑고 지질로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 세라미드, 피토스핑고신, 스핑고당지질 등을 들 수 있다. 스핑고 지질은 통상 포유류, 어류, 패류, 효모 또는 식물 등으로부터 통상의 방법에 의해 정제하거나 화학 합성법에 의해 취득할 수 있다.The sphingolipid may be any compound as long as it can be blended into cosmetics. Preferably, ceramide, phytosphingosine, sphingosaccharide lipid, and the like can be given. Sphingo lipids can usually be purified from mammals, fish, shellfish, yeasts or plants by conventional methods or obtained by chemical synthesis.
해초 엑기스로는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 갈조 엑기스, 홍조 엑기스, 녹조 엑기스 등을 들 수 있으며, 또, 이들의 해초 엑기스로부터 정제된 칼라기난, 아르긴산, 아르긴산나트륨, 아르긴산칼륨 등도 본 발명에서 사용되는 해초 엑기스에 포함된다. 해초 엑기스는 해초로부터 통상의 방법에 의해 정제하여 취득할 수 있다.The seaweed extract may be any compound as long as it can be blended into cosmetics. Preferably, the seaweed extract may include brown algae extract, red algae extract, green algae extract, and the like. Colorginine, arginate, sodium arginate, purified from these seaweed extracts, Potassium arginate and the like are also included in the seaweed extract used in the present invention. Seaweed extract can be obtained by purification from seaweed by conventional methods.
본 발명의 화장료에는 상기 필수 성분과 더불어 필요에 따라 통상 화장료에 배합되는 다른 성분을 배합해도 된다.In addition to the said essential component, you may mix | blend the cosmetics of this invention with the other components normally mix | blended with cosmetics as needed.
이외에 첨가해도 되는 배합 성분으로서는 유지 성분, 보습제, 에몰리엔트제, 계면 활성제, 유기 및 무기 안료, 유기 분체, 자외선 흡수제, 방부제, 살균제, 산화 방지제, 식물 추출물, pH 조정제, 알콜, 색소, 향료, 혈행 촉진제, 냉감제, 제한(制汗)제, 정제수 등을 들 수 있다.Other components that may be added include fats and oils, humectants, emollients, surfactants, organic and inorganic pigments, organic powders, ultraviolet absorbers, preservatives, fungicides, antioxidants, plant extracts, pH adjusters, alcohols, pigments, flavorings, Blood circulation accelerators, cooling agents, restriction agents, purified water and the like.
유지 성분으로서는 에스테르계 유지, 탄화수소계 유지, 실리콘계 유지, 불소계 유지, 동물 유지, 식물 유지 등을 들 수 있다.Examples of the fat or oil component include ester fats, hydrocarbon fats, silicone fats, fluorine fats, animal fats, and vegetable fats and oils.
에스테르계 유지로서는 트리2-에틸헥산산글리세릴, 2-에틸헥산산세틸, 미리스틴산이소프로필, 미리스틴산부틸, 팔미틴산이소프로필, 스테아르산에틸, 팔미틴산옥틸, 이소스테아르산이소세틸, 스테아르산부틸, 리놀레산에틸, 리놀레산이소프로필, 올레인산에틸, 미리스틴산이소세틸, 미리스틴산이소스테아릴, 팔미틴산이소스테아릴, 미리스틴산옥틸도데실, 이소스테아르산이소세틸, 세바신산디에틸, 아디핀산디이소프로필, 네오펜탄산이소알킬, 트리(카프릴, 카프린산)글리세릴, 트리2-에틸헥산산트리메틸롤프로판, 트리이소스테아르산트리메틸롤프로판, 테트라2-에틸헥산산펜타엘리슬리톨, 카프릴산세틸, 라우린산데실, 라우린산헥실, 미리스틴산데실, 미리스틴산미리스틸, 미리스틴산세틸, 스테아르산스테아릴, 올레인산데실, 리시노올레인산세틸, 라우린산이소스테아릴, 미리스틴산이소트리데실, 팔미틴산이소세틸, 스테아르산옥틸, 스테아르산이소세틸, 올레인산이소데실, 올레인산옥틸도데실, 리놀레산옥틸도데실, 이소스테아르산이소프로필, 2-에틸헥산산세토스테아릴, 2-에틸헥산산스테아릴, 이소스테아르산헥실, 디옥탄산에틸렌글리콜, 디올레인산에틸렌글리콜, 디카프린산프로필렌글리콜, 디(카프릴,카프린산)프로필렌글리콜, 디카프릴산프로필렌글리콜, 디카프린산네오펜틸글리콜, 디옥탄산네오펜틸글리콜, 트리카프릴산글리세릴, 트리운데실산글리세릴, 트리이소팔미틴산글리세릴, 트리이소스테아르산글리세릴, 네오펜탄산옥틸도데실, 옥탄산이소스테아릴, 이소노난산옥틸, 네오데칸산헥실데실, 네오데칸산옥틸도데실, 이소스테아르산이소세틸, 이소스테아르산이소스테아릴, 이소스테아르산옥틸데실, 폴리글리세린올레인산에스테르, 폴리글리세린이소스테아르산에스테르, 시트르산트리이소세틸, 시트르산트리이소알킬, 시트르산트리이소옥틸, 락트산라우릴, 락트산미리스틸, 락트산세틸, 락트산옥틸데실, 시트르산트리에틸, 시트르산아세틸트리에틸, 시트르산아세틸트리부틸, 시트르산트리옥틸, 말산디이소스테아릴, 히드록시스테아르산 2-에틸헥실, 숙신산디2-에틸헥실, 아디핀산디이소부틸, 세바신산디이소프로필, 세바신산디옥틸, 스테아르산콜레스테릴, 이소스테아르산콜레스테릴, 히드록시스테아르산콜레스테릴, 올레인산콜레스테릴, 올레인산디히드로콜레스테릴, 이소스테아르산피트스테릴, 올레인산피트스테릴, 12-스테알로일히드록시스테아르산이소세틸, 12-스테알로일히드록시스테아르산스테아릴, 12-스테알로일히드록시스테아르산이소스테아릴 등의 에스테르계 등을 들 수 있다.As ester fats and oils, glyceryl tri2-ethylhexanoate, cetyl 2-ethylhexanoate, isopropyl myristate, butyl mystinate, isopropyl palmitate, ethyl stearate, octyl palmitate, isocetyl isostearate, and stearic acid Butyl, ethyl linoleate, isopropyl linoleate, ethyl oleate, isocetyl acid isocetyl, isostyl acid isostearyl, isostaryl palmitate, octylate acid octylate decyl, isostearic acid isetyl, diethyl sebacate, adipine Acid isopropyl, isoalkyl neopentane, tri (capryl, capric acid) glyceryl, trimethyl ethyl trimethylolpropane, trimethyl stearate trimethylol propane, tetra 2-ethylhexanopenta sorbitol Cetyl caprylate, lauric acid decyl, hexyl laurate, decyl myristin, myristic acid myristyl, myritic acid cetyl, stearyl stearate, decyl oleate, rininooleic acid , Isostearyl laurate, isotridecyl myristin, isocetyl palmitate, octyl stearate, isocetyl stearate, isodecate oleate, octylate dodecyl oleate, octyl dodecyl linoleate, isopropyl isopropyl acid, 2 -Cetostearyl ethyl hexateate, stearyl 2-ethylhexanoate, hexyl isostearate, ethylene glycol dioctanoate, ethylene glycol dioleate, propylene glycol dicapric acid, propylene glycol dicacapate, capric acid Propylene glycol phthalic acid, neopentyl glycol dicapricate, neopentyl glycol dioctanoate, glyceryl tricaprylate, glyceryl tritridecylate, glyceryl triisopalmitine, glyceryl triisostearate, octyldodecyl neopentane Isostearyl octanoate, octyl isononanoate, hexyldecyl neodecanoate, octyldodecyl neodecanoate, isocetyl isostearate, isstearyl isostearate, Sothete octylate, polyglycerol oleate, polyglycerin isostearate, triisocetyl citrate, triisoalkyl citrate, triisoctyl citrate, lauryl lactate, myritic lactate, octyl lactate, octyl lactate Ethyl, acetyl triethyl citrate, acetyl tributyl citrate, trioctyl citrate, diisostearyl malate, 2-ethylhexyl hydroxystearate, di2-ethylhexyl succinate, diisobutyl adipicate, diisopropyl sebacinate, Dioctyl sebacate, cholesteryl stearate, cholesteryl isostearate, cholesteryl hydroxystearate, cholesteryl oleate, dihydrocholesteryl oleate, physteryl isostearate, phytic oleate, 12-Steloylhydroxystearate isocetyl, 12-stealoylhydroxystearate stearyl, 12-stealo Ester type | system | groups, such as monohydroxystearic acid isostearyl, etc. are mentioned.
탄화 수소계 유지로서는 스쿠알렌, 유동 파라핀, 알파-올레핀올리고머, 이소파라핀, 세레신, 파라핀, 유동 이소파라핀, 폴리부덴, 마이크로크리스탈린왁스, 와셀린 등의 탄화 수소계 유지 등을 들 수 있다.Hydrocarbon-based oils, such as squalene, a liquid paraffin, alpha-olefin oligomer, isoparaffin, ceresin, paraffin, a liquid isoparaffin, polybutene, microcrystal wax, and petrolatum, etc. are mentioned as a hydrocarbon oil-based fats and oils.
실리콘계 유지로서는 폴리메틸실리콘, 메틸페닐실리콘, 메틸시클로폴리실록산, 옥타메틸폴리실록산, 데카메틸폴리실록산, 도데카메틸시클로실록산, 디메틸실록산ㆍ메틸세틸옥시실록산 공중합체, 디메틸실록산ㆍ메틸스테알록시실록산 공중합체, 알킬 변성 실리콘유, 아미노 변성 실리콘유 등을 들 수 있다.Examples of the silicone-based oils and fats include polymethylsilicone, methylphenylsilicone, methylcyclopolysiloxane, octamethylpolysiloxane, decamethylpolysiloxane, dodecamethylcyclosiloxane, dimethylsiloxane, methylcetyloxysiloxane copolymer, dimethylsiloxane and methylsteoxysiloxane copolymer, and alkyl. Modified silicone oil, amino modified silicone oil and the like.
불소계 유지로서는 퍼플루오로폴리에테르 등을 들 수 있다.Perfluoro polyether etc. are mentioned as fluorine-based fats and oils.
동물 또는 식물 유지로서는 아보카도유, 아르몬드유, 올리브유, 참깨유, 쌀겨유, 새플라워유, 대두유, 옥수수유, 유채유, 행인(杏仁)유, 팜핵유, 팜유, 피마자유, 해바라기유, 포도종자유, 면실유, 야자유, 쿠쿠이너트유, 소맥배아유, 쌀 배아유, 시아버터, 월견초유, 마커데이미아너트유, 메도홈유, 난황유, 우지(牛脂), 마유, 밍크유, 오렌지라피유, 호호바유, 캔데리러왁스, 카르나바왁스, 액상 라놀린, 경화피마자유 등의 동물 또는 식물 유지를 들 수 있다.Animal or vegetable oils include avocado oil, almond oil, olive oil, sesame oil, rice bran oil, soybean oil, soybean oil, corn oil, rapeseed oil, almond oil, palm kernel oil, palm oil, castor oil, sunflower oil, grape seed oil. , Cottonseed oil, Palm oil, Cucumber nut oil, Wheat germ oil, Rice germ oil, Shea butter, Walnut colostrum oil, Marker demia nut oil, Meadow home oil, Egg yolk oil, Uji, Horse oil, Mink oil, Orange rape oil, Jojoba oil And animal or plant fats and oils such as candeler wax, carnava wax, liquid lanolin and hardened castor oil.
보습제로서는 수용성 저분자 보습제, 지용성 분자 보습제, 수용성 고분자, 지용성 고분자 등을 들 수 있다.As a humectant, a water-soluble low molecular humectant, a fat-soluble molecular moisturizer, a water-soluble polymer, a fat-soluble polymer, etc. are mentioned.
수용성 저분자 보습제로서는 세린, 글루타민, 솔비톨, 만니톨, 피롤리돈-카르복실산나트륨, 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 에틸렌글리콜, 폴리에틸렌글리콜B(중합도 n = 2 이상), 폴리프로필렌글리콜(중합도 n = 2 이상), 폴리글리세린B(중합도 n = 2 이상), 락트산, 락트산염 등을 들 수 있다.Water-soluble low molecular humectants include serine, glutamine, sorbitol, mannitol, pyrrolidone-sodium carboxylate, glycerin, propylene glycol, 1,3-butylene glycol, ethylene glycol, polyethylene glycol B (polymerization degree n = 2 or more), polypropylene Glycol (polymerization degree n = 2 or more), polyglycerol B (polymerization degree n = 2 or more), lactic acid, lactic acid salt, etc. are mentioned.
지용성 저분자 보습제로서는 콜레스테롤, 콜레스테롤에스테르 등을 들 수 있다.Examples of the fat-soluble low molecular humectants include cholesterol and cholesterol esters.
수용성 고분자로서는 카르복시비닐폴리머, 폴리아스파라긴산염, 트라가칸트, 크산탄검, 메틸셀룰로오스, 히드록시메틸셀룰로오스, 히드록시에틸셀룰로오스, 히드록시프로필셀룰로오스, 카르복시메틸셀룰로오스, 수용성 키틴, 키토산, 덱스트린 등을 들 수 있다.Examples of the water-soluble polymer include carboxyvinyl polymer, polyasparaginate, tragacanth, xanthan gum, methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, water soluble chitin, chitosan, and dextrin. Can be.
지용성 고분자로서는 폴리비닐피롤리돈ㆍ에이코센 공중합체, 폴리비닐피롤리돈ㆍ헥사데센 공중합체, 니트로셀룰로오스, 덱스트린지방산에스테르, 고분자 실리콘 등을 들 수 있다.Examples of the fat-soluble polymers include polyvinylpyrrolidone-eicosene copolymers, polyvinylpyrrolidone-hexadecene copolymers, nitrocellulose, dextrin fatty acid esters, polymer silicones, and the like.
에몰리엔트제로서는 장쇄아실글루타민산콜레스테릴에스테르, 히드록시스테아르산콜레스테릴, 12-히드록시스테아르산, 스테아르산, 로진산, 라놀린지방산콜레스테릴에스테르 등을 들 수 있다.Examples of the emollient include long chain acyl glutamic acid cholesteryl ester, hydroxy stearic acid cholesterol, 12-hydroxystearic acid, stearic acid, rosin acid, lanolin fatty acid cholesteryl ester, and the like.
계면 활성제로서는 비이온성 계면 활성제, 음이온성 계면 활성제, 양이온성 계면 활성제, 양성 계면 활성제 등을 들 수 있다.As surfactant, nonionic surfactant, anionic surfactant, cationic surfactant, amphoteric surfactant, etc. are mentioned.
비이온성 계면 활성제로서는 자기 유화형 모노스테아르산글리세린, 프로필렌글리콜지방산에스테르, 글리세린지방산에스테르, 폴리글리세린지방산에스테르, 솔비탄지방산에스테르, POE (폴리옥시에틸렌)솔비탄지방산에스테르, POE 솔비트지방산에스테르, POE 글리세린지방산에스테르, POE 알킬에테르, POE 지방산에스테르, POE 경화피마자유, POE 피마자유, POEㆍPOP (폴리옥시에틸렌ㆍ폴리옥시프로필렌) 공중합체, POEㆍPOP 알킬에테르, 폴리에테르변성실리콘, 라우린산알카놀아미드, 알킬아민옥시드, 수소첨가대두인지질 등을 들 수 있다.Examples of nonionic surfactants are self-emulsifying glycerin monostearate, propylene glycol fatty acid esters, glycerin fatty acid esters, polyglycerol fatty acid esters, sorbitan fatty acid esters, POE (polyoxyethylene) sorbitan fatty acid esters, POE sorbitan fatty acid esters, and POE. Glycerin fatty acid ester, POE alkyl ether, POE fatty acid ester, POE hardened castor oil, POE castor oil, POE / POP (polyoxyethylene / polyoxypropylene) copolymer, POE / POP alkyl ether, polyether modified silicone, lauric acid Alkanolamide, alkylamine oxide, hydrogenated soybean phospholipid, etc. are mentioned.
음이온성 계면 활성제로서는 지방산비누, 알파-아실술폰산염, 알킬술폰산염, 알킬알릴술폰산염, 알킬나프탈렌술폰산염, 알킬황산염, POE 알킬에테르황산염, 알킬아미드황산염, 알킬인산염, POE 알킬인산염, 알킬아미드인산염, 알킬로일알킬타우린염, N-아실아미노산염, POE 알킬에테르카르복실산염, 알킬술포숙신산염, 알킬술포아세트산나트륨, 아실화 가수분해 콜라겐펩티드염, 퍼플루오로알킬인산에스테르 등을 들 수 있다.As anionic surfactant, fatty acid soap, alpha-acyl sulfonate, alkyl sulfonate, alkyl allyl sulfonate, alkyl naphthalene sulfonate, alkyl sulfate, POE alkyl ether sulfate, alkylamide sulfate, alkyl phosphate, POE alkyl phosphate, alkylamide phosphate , Alkyloyl alkyl taurine salt, N-acylamino acid salt, POE alkyl ether carboxylate, alkyl sulfosuccinate, sodium alkyl sulfo acetate, acylated hydrolyzed collagen peptide salt, perfluoroalkyl phosphate ester, etc. are mentioned. .
양이온성 계면 활성제로서는 염화알킬트리메틸암모늄, 염화스테아릴트리메틸암모늄, 브롬화스테아릴트리메틸암모늄, 염화세토스테아릴트리메틸암모늄, 염화디스테아릴디메틸암모늄, 염화스테아릴디메틸벤질암모늄, 브롬화베헤닐트리메틸암모늄, 염화벤잘코늄, 스테아르산디에틸아미노에틸아미드, 스테아르산디메틸아미노프로필아미드, 라놀린 유도체 제 4급 암모늄염 등을 들 수 있다.As cationic surfactant, alkyl trimethylammonium chloride, stearyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, cetostearyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, stearyl dimethyl benzyl ammonium bromide, behenyl trimethyl ammonium chloride, chloride Benzalkonium, diethylaminoethyl stearate, dimethylaminopropyl stearate, lanolin derivatives, quaternary ammonium salts, and the like.
양성 계면 활성제로서는 카르복시베타인형, 아미드베타인형, 술포베타인형, 히드록시술포베타인형, 아미드술포베타인형, 포스포베타인형, 아미노카르복실산염형, 이미다졸린 유도체형, 아미드아민형 등의 양성 계면 활성제 등을 들 수 있다.Examples of amphoteric surfactants include carboxybetaine type, amidebetaine type, sulfobetaine type, hydroxysulfobetaine type, amide sulfobetaine type, phosphobetaine type, aminocarboxylate type, imidazoline derivative type and amideamine type. An amphoteric surfactant etc. are mentioned.
유기 및 무기 안료로서는 규산, 무수규산, 규산마그네슘, 탤크, 세리사이트, 마이카, 카올린, 벵갈라, 클레이, 벤토나이트, 티탄피막운모, 옥시염화비스무트, 산화지르코늄, 산화마그네슘, 산화아연, 산화티탄, 산화알루미늄, 황산칼슘, 황산바륨, 황산마그네슘, 탄산칼슘, 탄산마그네슘, 산화철, 군청, 산화크롬, 수산화크롬, 칼라민 및 이들의 복합체등의 무기 안료 ; 폴리아미드, 폴리에스테르, 폴리프로필렌, 폴리스티렌, 폴리우레탄, 비닐수지, 요소수지, 페놀수지, 불소수지, 규소수지, 아크릴수지, 멜라민수지, 에폭시수지, 폴리카보네이트수지, 디비닐벤젠ㆍ스티렌 공중합체, 실크파우더, 셀룰로오스, CI 피그먼트옐로우, CI 피그먼트오렌지 등의 유기 안료 및 이들의 무기 안료와 유기 안료의 복합 안료 등을 들 수 있다.Organic and inorganic pigments include silicic acid, silicic anhydride, magnesium silicate, talc, sericite, mica, kaolin, bengala, clay, bentonite, titanium film mica, bismuth oxychloride, zirconium oxide, magnesium oxide, zinc oxide, titanium oxide, aluminum oxide Inorganic pigments such as calcium sulfate, barium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, iron oxide, ultramarine blue, chromium oxide, chromium hydroxide, calamine and composites thereof; Polyamide, polyester, polypropylene, polystyrene, polyurethane, vinyl resin, urea resin, phenol resin, fluorine resin, silicon resin, acrylic resin, melamine resin, epoxy resin, polycarbonate resin, divinylbenzene, styrene copolymer, Organic pigments, such as a silk powder, a cellulose, CI pigment yellow, and CI pigment orange, and the composite pigment of these inorganic pigments and organic pigments, etc. are mentioned.
유기 분체로서는 스테아르산칼슘 등의 금속비누; 세틸린산아연나트륨, 라우릴린산아연, 라우릴린산칼슘 등의 알킬인산금속염; N-라우로일-베타-알라닌칼슘, N-라우로일-베타-알라닌아연, N-라우로일글리신칼슘 등의 아실아미노산 다가금속염; N-라우로일-타우린칼슘, N-팔미토일-타우린칼슘 등의 아미드술폰산 다가금속염; N-엡실론-라우로일-L-리진, N-엡실론-팔미토일리진, N-알파-파리토일올니틴, N-알파-라우로일아르기닌, N-알파-경화우지지방산아실아르기닌 등의 N-아실염기성아미노산; N-라우로일글리실글리신 등의 N-아실폴리펩티드; 알파-아미노카프릴산, 알파-아미노라우린산 등의 알파-아미노지방산; 폴리에틸렌, 폴리프로필렌, 나일론, 폴리메틸메타크릴레이트, 폴리스티렌, 디비닐벤젠ㆍ스티렌 공중합체, 사불화에틸렌 등을 들 수 있다.As organic powder, Metal soap, such as calcium stearate; Alkyl phosphate metal salts such as zinc sodium cetyl acid, zinc lauryl acid and calcium laurate; Acylamino acid polyvalent metal salts such as N-lauroyl-beta-alanine calcium, N-lauroyl-beta-alanine zinc, and N-lauroylglycine calcium; Amide sulfonic acid polyvalent metal salts, such as N-lauroyl-taurine calcium and N-palmitoyl-taurine calcium; N-epsilon-lauroyl-L-lysine, N-epsilon-palmitolysine, N-alpha-paratoylolnitine, N-alpha-lauroyl arginine, N-alpha-cured fatty acid acyl arginine Acyl basic amino acids; N-acylpolypeptides, such as N-lauroyl glycyl glycine; Alpha-amino fatty acids such as alpha-aminocaprylic acid and alpha-aminolauric acid; Polyethylene, polypropylene, nylon, polymethyl methacrylate, polystyrene, divinylbenzene-styrene copolymer, ethylene tetrafluoride and the like.
자외선 흡수제로서는 파라아미노벤조산, 파라아미노벤조산에틸, 파라아미노벤조산아밀, 파라아미노벤조산옥틸, 살리실산에틸렌글리콜, 살리신산페닐, 살리신산옥틸, 살리신산벤질, 살리신산부틸페닐, 살리신산호모멘틸, 계피산벤질, 파라메톡시계피산-2-에톡시에틸, 파라메톡시계피산옥틸, 디파라메톡시계피산모노-2-에틸헥산글리세릴, 파라메톡시계피산이소프로필, 디이소프로필ㆍ디이소프로필계피산에스테르 혼합물, 우로카닌산, 우로카닌산에틸, 히드록시메톡시벤조페논, 히드록시메톡시벤조페논술폰산 및 그 염, 디히드록시메톡시벤조페논, 디히드록시메톡시벤조페논디술폰산나트륨, 디히드록시벤조페논, 테트라히드록시벤조페논, 4-tert-부틸-4'-메톡시디벤조일메탄, 2,4,6-트리아닐리노-p-(카르보-2'-에틸헥실-1'-옥시)-1,3,5-트리아진, 2-(2-히드록시-5-메틸페닐)벤조트리아졸 등을 들 수 있다.Examples of the ultraviolet absorber include paraaminobenzoic acid, ethyl paraaminobenzoate, amyl paraaminobenzoic acid, octyl paraaminobenzoate, ethylene glycol salicylate, phenyl salicylate, octyl salicylate, benzyl salicylate, butylphenyl salicylate, homomentyl salicylic acid and benzyl cinnamic acid. , Paramethoxy cinnamic acid-2-ethoxyethyl, paramethoxy cinnamic acid octyl, diparamethoxy cinnamic acid mono-2-ethylhexane glyceryl, paramethoxy cinnamic acid isopropyl, diisopropyl diisopropyl cinnamic acid ester mixture, wuro Cananoic acid, ethyl urocanate, hydroxymethoxybenzophenone, hydroxymethoxybenzophenonesulfonic acid and salts thereof, dihydroxymethoxybenzophenone, dihydroxymethoxybenzophenone sodium sulfonate, dihydroxybenzophenone , Tetrahydroxybenzophenone, 4-tert-butyl-4'-methoxydibenzoylmethane, 2,4,6-trianilino-p- (carbo-2'-ethylhexyl-1'-oxy) -1 , 3,5-triazine, 2- (2-hydroxy Ci-5-methylphenyl) benzotriazole and the like.
살균제로서는 히노키티올, 트리클로산, 트리클로로히드록시디페닐에테르, 크로르헥시딘글루콘산염, 페녹시에탄올, 레조르신, 이소프로필메틸페놀, 아줄렌, 살리칠산, 진크필리티온, 염화벤잘코늄, 감광소 301 호, 모노니트로과이어콜나트륨, 운데시렌산 등을 들 수 있다.Examples of fungicides are hinokithiol, triclosan, trichlorohydroxydiphenyl ether, chlorhexidine gluconate, phenoxyethanol, resorcin, isopropylmethylphenol, azulene, salicylic acid, zinphylthione, benzalkonium chloride and photosensitive Sodium No. 301, sodium mononitroguicol, undecylenic acid, and the like.
산화 방지제로서는 부틸히드록시아니솔, 갈릭산프로필, 엘리소르빈산 등을 들 수 있다.Examples of the antioxidant include butylhydroxyanisole, propyl gallic acid, and erythorbic acid.
pH 조정제로서는 시트르산, 시트르산나트륨, 말산, 말산나트륨, 프말산, 프말산나트륨, 숙신산, 숙신산나트륨, 수산화나트륨, 인산일수소나트륨 등을 들 수 있다.Examples of the pH adjuster include citric acid, sodium citrate, malic acid, sodium malate, fmaric acid, sodium pmarate, succinic acid, sodium succinate, sodium hydroxide, sodium dihydrogen phosphate, and the like.
알코올로서는 세틸알코올 등의 고급 알코올을 들 수 있다.As alcohol, higher alcohols, such as cetyl alcohol, are mentioned.
또한, 이외에 첨가해도 되는 배합 성분은 이에 한정되는 것은 아니며, 또, 상기 어느 성분도 본 발명의 목적 및 효과를 손상시키지 않는 범위 내에서 배합 가능하다.In addition, the compounding component which may be added other than this is not limited to this, Moreover, any of the above components can also be mix | blended within the range which does not impair the objective and effect of this invention.
본 발명의 화장료 조성물은 용액, 유화물, 점성형 혼합물 등의 형상을 취할 수 있다.The cosmetic composition of the present invention may take the form of a solution, an emulsion, a viscous mixture, or the like.
본 발명의 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 추출물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및 담체를 포함한다.Ingredients included in the cosmetic composition of the present invention may include ingredients commonly used in cosmetic compositions in addition to the extract as an active ingredient, for example, conventional auxiliary agents such as stabilizers, solubilizers, vitamins, pigments and flavorings. And carriers.
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어 유액, 크림, 화장수, 팩, 파운데이션, 로션, 미용액, 모발화장료 등을 들 수 있다.The cosmetic composition of the present invention may be prepared in any formulation conventionally prepared in the art, and includes, for example, milky lotion, cream, lotion, pack, foundation, lotion, essence, hair cosmetic, and the like.
구체적으로, 본 발명의 화장료 조성물은 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클린저의 제형을 포함한다.Specifically, the cosmetic composition of the present invention skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisturizing lotion, nutrition lotion, massage cream, nutrition cream, moisturizing cream, hand cream, foundation, essence, nutrition essence, Formulations of packs, soaps, cleansing foams, cleansing lotions, cleansing creams, body lotions and body cleansers.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal carriers, plant fibers, waxes, paraffins, starches, tracantes, cellulose derivatives, polyethylene glycols, silicones, bentonites, silicas, talc or zinc oxide, etc. may be used as carrier components. Can be.
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used, in particular in the case of a spray, additionally chlorofluorohydrocarbon, propane Propellant such as butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solvating or emulsifying agent is used as the carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 Fatty acid esters of, 3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, liquid carrier diluents such as water, ethanol or propylene glycol, suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline Cellulose, aluminum metahydroxy, bentonite, agar or tracant and the like can be used.
본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing, the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, isethionate, an imidazolinium derivative, a methyltaurate, a sarcosinate, a fatty acid amide. Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
본 발명의 일 실험예에서는 그린볼 사과의 껍질 및 whole 사과 추출물의 생리활성을 비교한 결과, 그린볼 사과의 껍질추출물이 가장 높은 생리활성을 가지는 것을 확인하였다(실험예 1 참조).In an experimental example of the present invention, as a result of comparing the physiological activities of the greenball apple peel and whole apple extract, it was confirmed that the greenberry apple peel extract had the highest physiological activity (see Experimental Example 1).
본 발명의 다른 실험예에서는 그린볼 사과 껍질 및 whole 사과 추출물의 solid와 phenolic의 생리활성을 비교한 결과, 그린볼 사과 껍질의 phenolic compounds가 생리활성에 직접적으로 관여한다는 것을 확인하였다(실험예 2 참조).In another experimental example of the present invention, as a result of comparing the solid and phenolic physiological activities of the greenball apple peel and whole apple extract, it was confirmed that the phenolic compounds of the greenball apple peel were directly involved in the physiological activity (see Experimental Example 2). ).
본 발명의 또 다른 실험예에서는 그린볼 사과의 용매 종류별, 농도별 phenolic compound 추출 수율을 비교하였다.In another experimental example of the present invention was compared the extraction yield of phenolic compound by solvent type, concentration of greenball apple.
추출은 각 용매의 특성에 따라 시료에 함유된 생리활성 물질 및 기능성 물질을 분리하는 방법이며, 추출 시 사용되는 용매의 설정은 생리활성 실험 전 단계에 중요한 영향을 미친다. 순수한 증류수를 이용한 열수 추출은 용매에 대한 유해성의 문제가 없고, 수율이 높으며 수용성 물질 추출에 많이 이용되고 있으며, 극성 용매인 에탄올 추출의 경우 추출 후 정제가 쉬우며, 식물체의 tannin, saponin, organic acid 등 다양한 유용성분 추출에 주로 이용되고 있다.Extraction is a method of separating the physiologically active substances and functional substances contained in the sample according to the characteristics of each solvent, the setting of the solvent used in the extraction has an important effect on the pre-bioactivity experiment. Hot water extraction using pure distilled water has no problem of harmfulness to solvents, high yield, and is widely used for extracting water-soluble substances.In the case of ethanol extraction, which is a polar solvent, it is easy to purify after extraction, and tannin, saponin, and organic acid of plants. It is mainly used for the extraction of various useful components.
그린볼 사과의 껍질을 용매의 종류별로 추출하여 phenolic 함량을 측정한 결과, methanol, ethanol, water 순으로 높은 추출 수율을 나타내었으며, ethanol 농도별 추출물에서는 70% ethanol 추출물에서 가장 높은 추출 수율을 나타내었고, 그린볼 whole 사과는 60% ethanol 추출물에서 가장 높은 추출 수율을 나타내는 것을 확인하였다(실험예 3 참조).The extracts of greenball apples from different types of solvents were measured for the phenolic content, and the highest yields were obtained in the order of methanol, ethanol, and water, and the highest yields were obtained for 70% ethanol extracts. , Greenball whole apple was confirmed to show the highest extraction yield in 60% ethanol extract (see Experimental Example 3).
본 발명의 또 다른 실험예에서는 그린볼 사과 껍질추출물의 항산화 효과를 확인하였다.In another experimental example of the present invention, the antioxidant effect of the greenball apple peel extract was confirmed.
항산화물질은 체내의 세포내에서 해로운 반응을 일으키는 free radical이 DNA를 공격하거나, 지질을 산화시키기 전에 그들을 중화시켜 버린다. 따라서 항산화제는 인류가 현재 관심을 집중하는 기능성 혹은 생리활성물질의 하나로서 식품의 변질을 방지하고 인체에서의 노화 방지, 성인병 예방 등의 기능을 할 수 있는 물질로 알려져 있다. 항산화제는 반응성이 높아 체내 유해물질과 반응하여 세포내 주요 물질들이 활성산소에 의한 연쇄반응을 막아 주어 세포를 보호하는 역할을 한다. 체내에는 항산화 효소계인 superoxide dismutase (SOD), catalase, glutathione peroxidase (GSH-Px), glutathione S-transferase (GST) 등이 존재하며, 저분자로 항산화제 혹은 free radical scavenger 역할을 하는 항산화 물질인 vitamin C, vitamin E, β-carotin, carotenoids, flavonoids, 그리고 selenium을 비롯한 몇 가지 무기질 등이 인체를 보호하는 것으로 알려져 있다.Antioxidants neutralize free radicals before they attack DNA or oxidize lipids, causing harmful reactions in the cells of the body. Therefore, antioxidants are one of the functional or physiologically active substances that human beings are currently paying attention to, and are known as substances capable of preventing the deterioration of food, preventing aging in the human body, and preventing adult diseases. Antioxidants are highly reactive and react with harmful substances in the body to protect the cells by blocking the chain reaction caused by free radicals. The body contains antioxidant enzymes such as superoxide dismutase (SOD), catalase, glutathione peroxidase (GSH-Px), glutathione S-transferase (GST), and low-molecular antioxidant vitamin C, which acts as an antioxidant or free radical scavenger. Several minerals, including vitamin E, β-carotin, carotenoids, flavonoids, and selenium, are known to protect the body.
이에, 그린볼 사과 껍질추출물의 항산화 효과를 확인하기 위해 1,1-diphenyl-2-picrylhydrazyl (DPPH) 및 2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical 소거능, Antioxidant protection factor (PF), Thiobarbituric acid reactive substances (TBARs)를 측정하여 확인한 결과, 부사 사과 껍질추출물에 비해 그린볼 사과 껍질추출물이 뛰어난 항산화 효과를 나타냄을 확인하였다(실험예 4 참조).In order to confirm the antioxidant effect of Greenball apple peel extract, 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2'-Azinobis- (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging ability, Antioxidant protection factor (PF) and Thiobarbituric acid reactive substances (TBARs) were measured and confirmed, Green Apple apple bark extract showed an excellent antioxidant effect compared to the adverb apple bark extract (see Experimental Example 4).
본 발명의 또 다른 실험예에서는 그린볼 사과 껍질추출물의 항염증 효과를 확인하였다.In another experimental example of the present invention, the anti-inflammatory effect of the greenball apple peel extract was confirmed.
고분자의 hyaluronic acid (HA)는 염증 형성의 중요 요인인 macrophage의 phagocytic ability를 저해하는 반면, HA의 분해산물 혹은 저분자의 HA는 상처 치유 과정에서 inflammation, fibrosis, collagen deposition을 증가시킨다. 또한 hyaluronidase(HAase)는 일반적으로 항상성 유지를 위해 불활성 형태로 리소좀 등에 존재하고 있지만, 신체적 상해나 류마티즘과 같은 염증성 질환이 발병하였을 때 활성화 되어 혈관계 투과성 및 염증반응에 관여하므로 염증 유발 물질로 알려져 있으며, 알레르기 반응과 암세포 전이 등에도 관한다고 보고되었다.The hyaluronic acid (HA) of the polymer inhibits the phagocytic ability of macrophage, which is an important factor of inflammation formation, whereas the HA breakdown or small molecule HA increases inflammation, fibrosis and collagen deposition during wound healing. In addition, hyaluronidase (HAase) is generally present in lysosomes in an inactive form to maintain homeostasis. However, hyaluronidase (HAase) is known as an inflammation-inducing substance because it is activated when inflammatory diseases such as physical injury or rheumatism are involved and is involved in vascular permeability and inflammatory response. Allergic reactions and cancer cell metastasis have been reported.
이에, 그린볼 사과 껍질추출물의 항염증 효과를 평가하기 위해 hyaluronidase 저해 효과를 측정한 결과, 그린볼 사과 껍질추출물이 부사 껍질추출물에 비해 hyaluronidase 저해 효과가 더 뛰어나 우수한 항염증 효과를 나타냄을 확인하였다(실험예 5 참조).Thus, the hyaluronidase inhibitory effect was measured to evaluate the anti-inflammatory effect of the greenball apple peel extract, and the greenball apple peel extract showed a superior anti-inflammatory effect because the hyaluronidase inhibition effect was higher than that of the adverb peel extract ( See Experimental Example 5).
본 발명의 또 다른 실험예에서는 그린볼 사과 껍질추출물의 주름개선 효과를 확인하였다.In another experimental example of the present invention confirmed the wrinkle improvement effect of the greenball apple peel extract.
구조 단백질인 elastin은 피부 노화가 진행됨에 따라 생성량이 감소하고, 피부 노화 정도에 따라 type-1 collagenase의 생합성이 증가하여 진피 내 교원섬유 및 탄력섬유와 같은 기질 단백질의 분해를 유도하여 피부탄력을 떨어뜨리고 피부 주름의 생성을 야기한다. 인체의 중성구 과립구 내에 존재하는 elastase는 피부탄력성 섬유(elastin)을 분해하는 효소로 elastase의 저해는 피부 주름의 개선을 의미한다.The elastin, a structural protein, decreases as the skin ages, and the biosynthesis of type-1 collagenase increases according to the degree of skin aging, leading to degradation of matrix proteins such as collagen fibers and elastic fibers in the dermis. Knocks down and causes the formation of skin wrinkles. Elastase, which is present in human neutrophil granulocytes, is an enzyme that degrades skin elastic fibers (elastin). Inhibition of elastase means improvement of skin wrinkles.
또한, Collagen은 피부의 기계적 견고성과 결합조직의 저항력, 조직력, 세포분할과 분화를 유도하는 기능을 가지고 있으며, 자연노화에 따른 세포 활성 감소와 같은 내적요인과 여러 유해 환경에 의한 스트레스 증가, 자외선 조사에 의한 광노화와 같은 외적 요인에 의해 분해된다. 이러한 collagen의 감소는 피부의 탄력을 저하시켜 주름과 피부쳐짐의 원인이 된다고 보고되어 있다.In addition, collagen has the function of inducing mechanical strength of skin, resistance of tissue, tissue power, cell division and differentiation.Increasing stress due to internal factors such as decreased cell activity due to natural aging and harmful environment, UV irradiation Decomposed by external factors such as photoaging. This decrease in collagen is reported to reduce the elasticity of the skin and cause wrinkles and sagging.
이에, 그린볼 사과 껍질추출물의 주름개선 효과를 평가하기 위해 elastase 및 collagenase 저해 효과를 측정한 결과, 그린볼 사과 껍질추출물이 부사 껍질추출물에 비해 elastase 및 collagenase 저해 효과가 더 뛰어나 우수한 주름개선 효과를 나타냄을 확인하였다(실험예 6 참조).As a result of measuring the elastase and collagenase inhibitory effects to evaluate the antiwrinkle effect of greenball apple peel extract, the greenball apple peel extract showed better antiwrinkle effect than elastase and collagenase inhibitory effect compared to the adverb peel extract. It was confirmed (see Experimental Example 6).
이하, 본 발명의 바람직한 실시예 및 실험예를 첨부도면을 참조하여 상세히 설명하기로 한다. 다만, 이들 실시예 및 실험예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예 및 실험예에 의해 제한되는 것으로 해석되지는 않는다 할 것이다.Hereinafter, preferred embodiments and experimental examples of the present invention will be described in detail with reference to the accompanying drawings. However, these Examples and Experimental Examples are only for illustrating the present invention, and the scope of the present invention will not be construed as being limited by these Examples and Experimental Examples.
실시예Example 1. 재료 준비 1. Material Preparation
1-1. 1-1. 그린볼Green Ball 사과 시료 제조 Apple Sample Preparation
시험재료는 경북 군위군 소재의 사과연구소에서 교배조합으로 골든데리셔스(Golden delicious; 모본)와 후지(Fuji; 부본)를 교배하여 육성한 신 육성 품종인 그린볼 사과를 사용하였다. 시료는 그린볼 사과나무로부터 사과를 수확한 후 이물질을 제거하고 사과를 구성하고 있는 껍질 및 whole 사과를 대상으로 실험하였다. 껍질 및 whole 사과 시료는 동결건조(freeze dryer, FD8518, Ilshinbiobase, Yangju, Korea)하여 수분을 제거한 후 40 mesh로 분쇄하여 4℃ 저온고에 보관하며 시료로 사용하였다.The test materials used were Greenball apples, which are newly grown varieties that were bred by breeding Golden Delicious (Fubon) and Fuji (Fubon) as breeding combinations at the Apple Institute in Gyeongbuk County. The samples were harvested from green ball apple trees, and the foreign matters were removed and the skins and whole apples of apples were tested. Peel and whole apple samples were lyophilized (freeze dryer, FD8518, Ilshinbiobase, Yangju, Korea) to remove moisture and then crushed into 40 mesh and stored at 4 ℃ low temperature and used as samples.
1-2. 1-2. 그린볼Green Ball 사과로부터 From an apple phenol성phenolic 추출물 제조 Extract manufacturer
기능성 식품 및 기능성 화장품 활성 분석을 위한 추출물의 제조는 열수 추출물의 경우 상기 실시예 1-1에서 제조한 그린볼 사과의 시료 분말 1g을 증류수 200mL에 침지하여 추출물이 100mL가 될 때까지 가열한 후 냉각하여 24시간 동안 교반 추출하였으며, ethanol 추출물의 경우에는 상기 그린볼 사과 분말 1g에 10~100% 농도의 ethanol 100mL를 첨가하여 4℃의 shaking incubator에서 24시간 동안 교반 추출하였다. 각 추출물은 Whatman No. 1 filter paper (Whatman inc., piscataway, New jersey, USA)로 여과한 후 필요에 따라 rotary vacuum evaporator (Eyela NE, Tokyo, Japan)에서 농축하여 4℃ 냉장고에서 저온 보관하며, 시료의 phenolic compounds 농도를 각각 25, 50, 75, 100 ㎍/mL 또는 50, 100, 150, 200 ㎍/mL phenolics 농도로 설정하여 실험에 사용하였다.Preparation of extracts for the analysis of functional foods and functional cosmetics activity, in the case of hot water extracts, 1 g of the sample powder of greenball apples prepared in Example 1-1 was immersed in 200 mL of distilled water and heated until the extract became 100 mL and then cooled. The extract was stirred for 24 hours, and in the case of ethanol extract, 100 mL of 10-100% ethanol was added to 1 g of the greenball apple powder, followed by stirring extraction for 24 hours in a shaking incubator at 4 ° C. Each extract contains Whatman No. 1 filter paper (Whatman inc., Piscataway, New jersey, USA), and then, if necessary, concentrate in a rotary vacuum evaporator (Eyela NE, Tokyo, Japan) and store at low temperature in a 4 ℃ refrigerator. 25, 50, 75, 100 µg / mL or 50, 100, 150, 200 µg / mL phenolics concentrations were used for the experiment, respectively.
실시예Example 2. 실험 방법 2. Experimental method
2-1. Total phenolic compounds 함량 정량2-1. Total phenolic compound content quantification
Total phenolic 정량은 Folin과 Denis의 방법에 준하여 추출물 1 mL에 95% ethanol 1 mL와 증류수 5 mL를 첨가하고 1 N Folin-ciocalteu reagent 0.5 mL를 잘 섞어 5분간 방치한 후 Na2CO3 1 mL를 가하여 흡광도 725 nm에서 1시간 이내에 측정하여 gallic acid를 이용한 표준곡선으로부터 양을 환산하였다.For total phenolic quantification, 1 mL of 95% ethanol and 5 mL of distilled water were added to 1 mL of extract according to the method of Folin and Denis. After mixing 0.5 mL of 1 N Folin-ciocalteu reagent for 5 minutes, 1 mL of Na 2 CO 3 was added. The absorbance was measured within 1 hour at 725 nm, and the amount was converted from the standard curve using gallic acid.
2-2. 1,1-2-2. 1,1- diphenyldiphenyl -2--2- picrylhydrazylpicrylhydrazyl ( ( DPPHDPPH ) radical 저해 효과 측정) Radical Inhibition Effect Measurement
DPPH radical 저해 효과는 Blois의 방법에 준하여, 시료 0.5 mL에 60 μM DPPH 3 mL를 넣고 vortex한 후 15분 동안 방치한 다음 517 nm에서 흡광도를 측정하였다.DPPH radical inhibition effect according to the method of Blois, immersed 3 mL of 60 μM DPPH in 0.5 mL of the sample and allowed to stand for 15 minutes and the absorbance was measured at 517 nm.
2-3. 2,2'-2-3. 2,2'- AzinobisAzinobis -(3--(3- ethylbenzothiazolineethylbenzothiazoline -6--6- sulfonicsulfonic acid) ( acid) ( ABTSABTS ) radical 저해 효과 측정) Radical Inhibition Effect Measurement
ABTS radical 저해 효과는 Fellegrini 등의 방법에 준하여, 시료 7 mM ABTS와 140 mM K2S2O8을 5 mL:88 μL로 섞어 어두운 곳에 12~16시간 방치시킨 후, 이를 ethanol과 1:88의 비율로 섞어 734 nm에서 대조구의 흡광도 값이 0.7±0.02가 되도록 조절한 ABTS solution을 사용하여 시료용액 50 μL와 ABTS solution 1 mL를 30초 동안 섞은 후 2.5분간 incubation하여 734 nm에서 흡광도를 측정하였다.ABTS radical inhibition effect according to the method of Fellegrini et al., Mixed with 7 mM ABTS and 140 mM K 2 S 2 O 8 in 5 mL: 88 μL and left in a dark place for 12-16 hours, and then ethanol 1:88 The mixture was mixed at a ratio of 734 nm, and the absorbance value of the control was adjusted to 0.7 ± 0.02. The ABTS solution was mixed with 50 μL of sample solution and 1 mL of ABTS solution for 30 seconds and then incubated for 2.5 minutes to measure absorbance at 734 nm.
2-4. Antioxidant protection factor (2-4. Antioxidant protection factor ( PFPF ) 측정) Measure
PF 측정은 Andarwulan과 Shetty의 방법에 준하여, 10 mg의 β-carotene을 50 mL의 chloroform에 녹인 용액 1 mL를 evaporator용 수기에 넣고 40℃ water bath에서 chloroform을 증류시킨 후 20 μL linoleic acid, 184 μL tween 40과 50 mL H2O2를 가하여 emulsion을 만들고, 5 mL의 emulsion에 시료 100 μL를 혼합하여 vortex로 잘 섞어 준 뒤 50℃에서 30분간 반응 시켜 냉각시킨 다음, 470 nm에서 흡광도를 측정하였다.PF measurement was carried out according to Andarwulan and Shetty's method. 1 mL of a solution of 10 mg β-carotene in 50 mL of chloroform was placed in an evaporator water, and chloroform was distilled in a 40 ° C water bath. 20 μL linoleic acid, 184
2-5. 2-5. ThiobarbituricThiobarbituric acid reactive substances ( acid reactive substances ( TBARsTBARs ) 저해 효과 측정) Inhibition effect measurement
TBARs 저해 효과는 Buege와 Aust의 방법에 준하여, 1% linoleic acid와 1% Tween 40으로 emulsion을 만들고 emulsion 0.8 mL와 시료 0.2 mL를 섞은 후 50℃ water bath에서 10시간 반응시켰다. 반응액 1 mL에 TBA regent 2 mL를 가하고 15분간 boiling한 다음 10분간 냉각시키고, 15분간 1,000 rpm으로 원심분리하여 실온에서 10분간 방치 후 상등액을 532 nm에서 흡광도를 측정하였다.TBARs inhibition effect was made by 1% linoleic acid and 1
2-6. 2-6. HyaluronidaseHyaluronidase 저해 효과 측정 Inhibition effect measurement
Hyaluronidase (HAase)저해 효과는 Dorfman와 OTT의 방법에 준하여, sodium-hyaluronic acid (HA)로부터 형성된 N-acetyl-glucosamine을 glucoxazoline 유도체로 변형시킨 후 ρ-dimethylaminobenzaldehyde (DMAB)로 발색시켜 흡광도 600 nm에서 측정하였다.Hyaluronidase (HAase) inhibitory effect was measured by absorbance at 600 nm by modifying N-acetyl-glucosamine formed from sodium-hyaluronic acid (HA) to glucoxazoline derivative followed by color development with ρ-dimethylaminobenzaldehyde (DMAB) according to Dorfman and OTT method. It was.
2-7. 2-7. ElastaseElastase 저해 효과 측정 Inhibition effect measurement
Elastase 저해 효과는 Kraunsoe 등의 방법에 준하여, 0.2 M Tris-HCl buffer (pH 8.0) 1 mL에 기질액 0.8 mM N-succinyl-(Ala)3-ρ-nitroanilide 용액 0.1 mL의 혼합액에 1.0 U/mL porcine pancreatic elastase (PPE) (Sigma-Aldrich Co.) 효소용액 0.1 mL와 50~200 μg/mL phenolic compounds 농도의 각 시료 0.1 mL를 넣고 대조구에는 시료 대신 증류수 0.1 mL를 첨가하여 25℃에서 20분간 반응시킨 후 ρ-nitroaniline 생성량을 흡광도 410 nm에서 측정하였다.Elastase inhibitory effect was 1.0 U / mL in a mixture of 0.1 mL of 0.8 mM N-succinyl- (Ala) 3-ρ-nitroanilide solution in 1 mL of 0.2 M Tris-HCl buffer (pH 8.0) according to Kraunsoe et al. Add 0.1 mL of porcine pancreatic elastase (PPE) (Sigma-Aldrich Co.) enzyme solution and 0.1 mL of each sample of 50 ~ 200 μg / mL phenolic compounds, and add 0.1 mL of distilled water instead of the sample to the control. After the ρ-nitroaniline production was measured at absorbance 410 nm.
2-8. 2-8. CollagenaseCollagenase 저해 효과 측정 Inhibition effect measurement
Collagenase 저해 효과는 Wunsch와 Heidrich의 방법에 준하여, 0.1 M Tris-HCl buffer (pH 7.5)에 4 mM CaCl2를 첨가하여 4-phenylazobenzyloxycarbonyl-Pro- Leu-Gly-Pro-D-Arg (0.3 mg/mL)를 녹인 기질액 0.25 mL와 50~200 μg/mL phenolic compounds 농도의 각 시료 용액 0.1 mL의 혼합액에 0.2 mg/mL collagenase (Sigma-Aldrich Co.) 0.15 mL를 첨가하여 실온에서 20분간 방치한 후 6% citric acid 0.5 mL를 넣어 반응을 정지시킨 다음, ethyl acetate 2 mL를 첨가하고 320 nm에서 흡광도를 측정하였다.Collagenase inhibitory effect was obtained by adding 4 mM CaCl 2 to 0.1 M Tris-HCl buffer (pH 7.5) according to Wunsch and Heidrich's method (4-mgazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg (0.3 mg / mL). ) 0.15 mL of 0.2 mg / mL collagenase (Sigma-Aldrich Co.) was added to a mixed solution of 0.25 mL of dissolved substrate solution and 0.1 mL of each sample solution having a concentration of 50 to 200 μg / mL phenolic compounds. 0.5 mL of 6% citric acid was added to stop the reaction. 2 mL of ethyl acetate was added thereto, and the absorbance was measured at 320 nm.
2-9. 통계적 분석2-9. Statistical analysis
통계적 분석은 Duncan's multiple range test에 의해 수행되었으며, 그래프에 표시된 서로 다른 위첨자 문자는 P<0.05에서 유의적인 차이를 의미한다.Statistical analysis was performed by Duncan's multiple range test, and the different superscript characters in the graph indicate significant differences at P <0.05.
실험예Experimental Example 1. One. 그린볼Green Ball 사과 껍질과 whole 사과 추출물의 생리활성 비교 Comparison of Biological Activities between Apple Peel and Whole Apple Extract
상기 실시예 1-2의 방법으로 그린볼 사과의 껍질과 whole 사과를 water와 60% ethanol로 추출하여 상기 실시예 2-1의 방법으로 phenolic 함량을 측정한 결과, 도 1에 나타낸 바와 같이 껍질에서 가장 높은 phenolic 함량을 나타내었다. 따라서, 껍질 추출물의 생리활성이 가장 높은 수준을 나타낼 것으로 추측되었다.As a result of measuring the phenolic content by the method of Example 2-1 by extracting the peel of greenball apples and whole apples with water and 60% ethanol by the method of Example 1-2, as shown in Figure 1 It showed the highest phenolic content. Therefore, it was speculated that the physiological activity of the bark extract showed the highest level.
또한, 그린볼 사과의 껍질과 whole 사과 추출물의 생리적 효과를 평가하기 위해 주름개선 효과 중 하나인 collagenase 억제 효과를 상기 실시예 2-8의 방법으로 측정한 결과, 도 2에 나타낸 바와 같이 사과의 껍질에서 효능이 높게 나타났고, 과육이 포함된 whole 사과에서는 낮은 수준의 collagenase 저해 효과가 나타났다. In addition, in order to evaluate the physiological effects of the peel of greenball apples and the whole apple extract, the collagenase inhibitory effect, which is one of the anti-wrinkle effects, was measured by the method of Example 2-8, and as shown in FIG. Efficacy was high in, and low levels of collagenase inhibition were found in whole apples containing flesh.
도 2의 그래프에서 PW는 그린볼 사과의 껍질 물 추출물(peel water extracts), PE는 그린볼 사과의 껍질 에탄올 추출물(peel ethanol extracts), WhW는 그린볼 whole 사과의 물 추출물(whole fruit water exracts), WhE는 그린볼 whole 사과의 에탄올 추출물(whole fruit ethanol extracts)을 의미한다. In the graph of FIG. 2, PW is peel water extracts of greenball apples, PE is peeled ethanol extracts of greenball apples, and WhW is whole fruit water exracts of greenball whole apples. WhE refers to whole fruit ethanol extracts of greenball whole apples.
상기 결과에 따라 그린볼 사과의 껍질과 whole 사과를 비교하였을 때, 껍질에서 phenolic 함량이 높게 나타났으며, 주름개선 활성에서도 과육이 포함된 whole사과보다는 껍질이 높은 주름개선 활성을 나타내는 것을 확인하였다. 따라서, 이후 실험에는 효능이 높았던 그린볼 사과의 껍질을 대상으로 실험을 진행하였다.According to the results, when comparing the green apples with the peel of apples, the phenolic content was higher in the peel, and the peel improved activity than the whole apple containing the flesh was confirmed that the wrinkles showed higher wrinkle improvement activity. Therefore, the experiment was carried out in the experiment of the skin of the apple of greenball was high efficacy.
실험예Experimental Example 2. 2. 그린볼Green Ball 사과 껍질 및 whole 사과 추출물의 solid와 phenolic의 생리활성 비교 Comparison of Physiological Activities of Solid and Phenolic Extracts from Apple Peel and Whole Apple Extract
사과의 고형분과 phenolic 성분의 생리활성 효능 비교를 위해 상기 실시예 2-2의 방법으로 DPPH radical 소거능을 측정한 결과, 도 3a에 나타낸 바와 같이 그린볼 사과 껍질 water, ethanol 추출물의 100 ㎍/mL 농도의 고형분에서는 각각 58.95%와 69.28%의 전자공여능을 나타내었으나, 100 ㎍/mL phenolic 농도에서 각각 92.47%와 80.62%의 전자공여능을 나타내어 phenolic compound에 의해 활성을 나타내는 것으로 확인되었으며, whole 사과의 water, ethanol 추출물의 100 ㎍/mL 농도의 고형분에서는 도 3b에 나타낸 바와 같이, 각각 25.84%와 29.62%의 전자공여능을 나타내었으나, 100 ㎍/mL phenolic 농도에서 각각 90.78%와 84.01%의 전자공여능을 나타내어 phenolic compound에 의해 활성을 나타내는 것으로 확인되었다. As a result of measuring the DPPH radical scavenging ability by the method of Example 2-2 for comparing the physiological activity effect of the solid content of the apple and the phenolic component, 100 ㎍ / mL concentration of the greenball apple peel water and ethanol extract as shown in FIG. In the solid content of, it showed 58.95% and 69.28% electron donating ability, respectively, but it showed the electron donating ability of 92.47% and 80.62% at 100 ㎍ / mL phenolic concentration, respectively, and showed activity by phenolic compound. In the 100 ㎍ / mL solid content of the ethanol extract showed 25.84% and 29.62% electron donating ability, respectively, as shown in Figure 3b, but 90.78% and 84.01% electron donating ability at 100 ㎍ / mL phenolic concentration, respectively It was found to be active by the compound.
또한, 고형분과 phenolic 성분의 생리활성 효능을 비교를 위해 상기 실시예 2-3의 방법으로 ABTS radical 소거능을 측정한 결과, 도 3c에 나타낸 바와 같이 사과 껍질의 water, ethanol 추출물 100 ㎍/mL 농도의 고형분에서 각각 9.93%와 9.53%의 전자공여능을 나타내었으며, 100 ㎍/mL phenolic 농도에서 각각 89.15%와 83.08%의 전자공여능을 나타내었고, whole 사과의 water, ethanol 추출물의 100 ㎍/mL 농도의 고형분에서는 도 3d에 나타낸 바와 같이, 각각 5.61%와 4.02%의 전자공여능을 나타내었으나, 100 ㎍/mL phenolic 농도에서 각각 90.34%와 91.44%의 전자공여능을 나타내어, phenolic compound에 의해 활성을 나타내는 것으로 확인되었고, 사과의 생리활성은 고형분 중에 함유된 phenolic compound에 의해 활성이 지배되는 것으로 다시 확인되었다. In addition, as a result of measuring ABTS radical scavenging ability by the method of Example 2-3 to compare the physiological activity effect of the solid content and phenolic component, as shown in Figure 3c of apple peel water,
따라서, 고형분과 phenolic 성분의 생리활성 효능을 비교실험한 결과, 사과 껍질의 phenolic compounds가 생리활성에 직접적으로 관여한다는 것을 확인하였으며, 이에 사과의 껍질부분의 phenolic compound를 추출하여 실험을 진행하였다.Therefore, as a result of comparing the physiological activity of the solid content and phenolic components, it was confirmed that the phenolic compounds of the apple peel is directly involved in the physiological activity, and the experiment was conducted by extracting the phenolic compound of the apple peel.
실험예Experimental Example 3. 3. 그린볼Green Ball 사과의 용매 종류별, 농도별 phenolic compound 추출수율 비교 Comparison of Extraction Yields of Phenol Compounds by Apple Solvent Type and Concentration
그린볼 사과의 껍질을 용매의 종류별로 추출하여 phenolic 함량을 측정한 결과, 도 4a에 나타낸 바와 같이 methanol, ethanol, water, acetone, butanol, ethyl acetate 순으로 7.46, 6.38, 5.30, 3.31, 3.24, 2.36 mg/g의 phenolic 함량을 나타내었으며, 그린볼 사과의 껍질 ethanol 농도별 추출물에서는 도 4b에 나타낸 바와 같이 70% ethanol 추출물에서 8.31 mg/g으로 phenolic 함량의 가장 높은 추출 수율을 나타내었다.As a result of measuring the phenolic content by extracting the peel of greenball apple by the type of solvent, as shown in Figure 4a, methanol, ethanol, water, acetone, butanol, ethyl acetate in the order 7.46, 6.38, 5.30, 3.31, 3.24, 2.36 The phenolic content of mg / g was shown, and the extract of green berry apple peel by ethanol concentration showed the highest extraction yield of phenolic content as 8.31 mg / g in 70% ethanol extract as shown in FIG. 4b.
또한, 그린볼 whole 사과의 ethanol 농도별 추출물에서는 도 4c에 나타낸 바와 같이 60% ethanol 추출물에서 3.49 mg/g으로 phenolic 함량의 가장 높은 추출 수율을 나타내었다. In addition, the ethanol concentration of the greenball whole apple extract showed the highest extraction yield of phenolic content as 3.49 mg / g in 60% ethanol extract as shown in Figure 4c.
따라서, 그린볼 사과의 껍질, whole 사과를 water 및 각각 70% ethanol, 60% ethanol을 용매로 사용하여 추출물을 제조하고 실험을 진행하였다. Therefore, the extract of greenball apples and whole apples using water, 70% ethanol, and 60% ethanol as solvents were used for the extraction.
그린볼 사과의 껍질과 whole 사과 추출물간의 phenolic compounds 함량 차이에서는 껍질 추출물이 whole 사과 추출물보다 약 2.3배 정도의 높은 함량을 나타내었다. The difference in the content of phenolic compounds between the peels of greenball apples and whole apple extracts was about 2.3 times higher than that of whole apple extracts.
상기 결과에 따라 water, 70% 및 60% ethanol로 추출한 추출물은 실험의 재현성을 위해 phenolic 함량을 25~200 ㎍/mL으로 조절하여 항산화, 항염증, 주름개선 활성을 검증하였다.According to the results, the extract extracted with water, 70% and 60% ethanol was tested for antioxidant, anti-inflammatory, anti-wrinkle activity by adjusting the phenolic content to 25 ~ 200 ㎍ / mL for reproducibility of the experiment.
실험예Experimental Example 4. 4. 그린볼Green Ball 사과 껍질추출물의 항산화 효과 확인 Antioxidant Effect of Apple Peel Extract
4-1. 1,1-4-1. 1,1- diphenyldiphenyl -2--2- picrylhydrazylpicrylhydrazyl ( ( DPPHDPPH ) radical 저해 효과 확인) Inhibition of radical inhibition effect
그린볼 사과 껍질추출물의 항산화 효과를 평가하기 위해 상기 실시예 2-2의 방법으로 DPPH radical 소거능을 측정한 결과, 도 5에 나타낸 바와 같이 그린볼 사과 껍질의 water 추출물(GPW) 및 ethanol 추출물(GPE)의 25~100 ㎍/mL phenolic 농도에서 각각 82.94~88.26, 89.56~100.00%의 radical 소거능을 나타내었다. 또한, 대조군으로 사용한 부사 품종의 껍질의 water추출물(BPW), 및 ethanol 추출물(BPE)은 85.16~87.55, 87.80~94.40%의 radical 소거능을 나타내 부사 품종에 비해 그린볼 사과의 껍질추출물이 더 우수한 전자공여능을 나타내어 DPPH radical 저해 효과가 뛰어난 것을 알 수 있었다.DPPH radical scavenging activity was measured by the method of Example 2-2 to evaluate the antioxidant effect of greenball apple peel extract, as shown in FIG. 5, water extract (GPW) and ethanol extract (GPE) of greenball apple peel ) Showed radical scavenging ability of 82.94 ~ 88.26 and 89.56 ~ 100.00% at 25 ~ 100 ㎍ / mL phenolic concentration, respectively. In addition, the water extract (BPW) and ethanol extract (BPE) of the bark of the adverb varieties used as a control showed 85.16 to 87.55 and 87.80 to 94.40% radical scavenging activity, and the green ball apple peel extract was better than the adverb varieties. The donor ability was found to be excellent DPDP radical inhibitory effect.
4-2.4-2. 2,2'-2,2'- AzinobisAzinobis -(3--(3- ethylbenzothiazolineethylbenzothiazoline -6--6- sulfonicsulfonic acid) ( acid) ( ABTSABTS ) radical 저해 효과 확인) Inhibition of radical inhibition effect
그린볼 사과 껍질추출물을 이용하여 상기 실시예 2-3의 방법으로 ABTS radical 소거능을 측정한 결과, 도 6에 나타낸 바와 같이 그린볼 사과 껍질의 water 추출물(GPW), 및 ethanol 추출물(GPE)의 25~100 ㎍/mL phenolic 농도에서 각각 44.36~99.27, 41.99~99.09%의 radical 소거능을 나타내었다. 또한, 대조군으로 사용한 부사 품종 껍질의 water 추출물(BPW), 및 ethanol 추출물(BPE)은 40.15~99.46, 38.70~98.22%의 radical 소거능을 나타내어 그린볼 사과 껍질추출물과 비슷한 전자공여능을 나타내었으며, 상기와 같이 그린볼 사과 껍질추출물은 수용성 항산화능을 나타내는 DPPH, ABTS radical 소거능에서 매우 높은 활성을 확인하였다.As a result of measuring the ABTS radical scavenging ability by the method of Example 2-3 using the green ball apple peel extract, as shown in Figure 6 of the water extract (GPW), and ethanol extract (GPE) of the green ball apple peel At ˜100 ㎍ / mL phenolic concentration, 44.36 ~ 99.27 and 41.99 ~ 99.09% radical scavenging activity were observed. In addition, the water extract (BPW) and ethanol extract (BPE) of the adverb varietal bark used as a control showed radical scavenging ability of 40.15 ~ 99.46, 38.70 ~ 98.22%, and showed electron donating ability similar to that of greenball apple peel extract. Likewise, greenball apple peel extracts showed very high activity in DPPH and ABTS radical scavenging ability.
4-3.4-3. Antioxidant protection factor (Antioxidant protection factor ( PFPF ) 확인) Confirm
11개의 이중 결합으로 구성되어 있어 높은 불포화 성질을 가지고 있는 β-carotine은 peroxyl radical과 매우 쉽게 반응하는데, 불포화된 탄소 중 하나에 선택적 연쇄 절단되어 항산화제로서 작용하는 성질을 이용하여 지용성 항산화능을 나타내는 PF를 상기 실시예 2-4의 방법으로 측정하였다. Β-carotine, which is composed of 11 double bonds and has high unsaturated properties, reacts very easily with peroxyl radicals, and it shows a fat-soluble antioxidant activity by using selective chain cleavage to one of the unsaturated carbons and acting as an antioxidant. PF was measured by the method of Example 2-4.
그 결과, 도 7에 나타낸 바와 같이 그린볼 사과 껍질의 water 추출물(GPW), 및 ethanol 추출물(GPE)의 25~100 ㎍/mL phenolic 농도에서 각각 1.23~1.43, 1.19~1.21 PF를 나타내었으며, 대조군으로 사용한 부사 품종 껍질의 water 추출물(BPW), 및 ethanol 추출물(BPE)은 25~100 ㎍/mL phenolic 농도에서 각각 1.22~1.29, 1.26~1.37 PF를 나타내어 부사 품종에 비해 그린볼 사과 껍질의 water 추출물이 더 우수한 지용성 항산화능을 나타내는 것을 확인하였다.As a result, as shown in Figure 7, the greenball apple peel water extract (GPW), and ethanol extract (GPE) of 1.23 ~ 1.43, 1.19 ~ 1.21 PF at 25 ~ 100 ㎍ / mL phenolic concentrations, respectively, the control group Water extract (BPW) and ethanol extract (BPE) of the adverb varietal bark were used as 1.22 ~ 1.29 and 1.26 ~ 1.37 PF at 25 ~ 100 ㎍ / mL phenolic concentration, respectively. It was confirmed that this shows a better fat-soluble antioxidant capacity.
4-4. 4-4. ThiobarbituricThiobarbituric acid reactive substances ( acid reactive substances ( TBARsTBARs ) 저해 효과 확인) Confirmation of Inhibitory Effect
그린볼 사과 껍질추출물을 이용하여 또 다른 지용성 항산화능을 나타내는 TBARs의 저해활성을 상기 실시예 2-5의 방법으로 측정한 결과, 도 8에 나타낸 바와 같이 그린볼 사과 껍질의 water 추출물(GPW), 및 ethanol 추출물(GPE)에서 각각 24.88~60.29, 29.66~75.92%의 TBARs의 저해활성을 나타내었다. 또한, 대조군으로 사용한 부사 품종 껍질의 water 추출물(BPW), 및 ethanol 추출물(BPE)은 각각 32.60~55.40, 20.57~72.48%의 TBARs의 저해활성을 나타내었다. 상기 결과로부터, 그린볼 사과 껍질추출물이 부사 품종의 사과에 비해 더 우수한 지용성 항산화능을 가진 것으로 확인되었다. As a result of measuring the inhibitory activity of TBARs showing another fat-soluble antioxidant activity using the greenball apple peel extract by the method of Example 2-5, as shown in FIG. 8, the water extract (GPW) of the greenball apple peel, And ethanol extract (GPE) showed inhibitory activity of TBARs of 24.88 ~ 60.29 and 29.66 ~ 75.92%, respectively. In addition, the water extract (BPW) and ethanol extract (BPE) of the adverb varieties bark used as a control showed the inhibitory activity of TBARs of 32.60 ~ 55.40, 20.57 ~ 72.48%, respectively. From the above results, it was confirmed that the greenball apple peel extract has a better fat-soluble antioxidant capacity than the apples of the adverb varieties.
따라서, 그린볼 사과 껍질추출물은 부사 품종에 비해 높은 항산화 활성을 가짐으로 인해서 항노화를 위한 기능성 소재로 활용이 가능할 것으로 판단되었다.Therefore, the greenball apple peel extract has a high antioxidant activity compared to the adverb varieties, it was determined that it can be used as a functional material for anti-aging.
실험예Experimental Example 5. 5. 그린볼Green Ball 사과 껍질추출물의 항염증 효과 확인 Anti-inflammatory Effects of Apple Peel Extracts
그린볼 사과 껍질추출물의 항염증 효과를 확인하기 위해 염증 유발에 관련이 있는 효소인 hyaluronidase(HAase) 저해 효과를 상기 실시예 2-6의 방법으로 측정하였다. In order to confirm the anti-inflammatory effect of Greenball apple peel extract, the inhibitory effect of hyaluronidase (HAase), an enzyme related to inflammation, was measured by the method of Example 2-6.
그 결과, 도 9에 나타낸 바와 같이 그린볼 사과 껍질의 water 추출물(GPW)에서는 50~200 ㎍/mL의 phenolic 농도에서 0.00~6.45%의 저해 효과를 나타내었고, 그린볼 사과 껍질의 ethanol 추출물(GPE)에서는 50~200 ㎍/mL의 phenolic 농도에서 13.16~20.78%의 저해 효과를 나타내었다. 또한, 대조군으로 사용한 부사 품종 껍질의 water 추출물(BPW)은 50~200 ㎍/mL의 phenolic 농도에서 0.03~1.79%의 저해 효과를 나타내었고, 부사 품종 껍질의 ethanol 추출물(BPE)에서는 50~200 ㎍/mL의 phenolic 농도에서 1.29~12.72%의 저해 효과를 나타내어, 그린볼 사과 껍질추출물이 부사 껍질 추출물에 비해 더 우수한 항염증 효과를 나타내었고, 특히 ethanol 추출물에서 상대적으로 부사보다 더 높은 항염증 효과를 나타내었다.As a result, as shown in Figure 9 green water apple peel (GPW) showed an inhibitory effect of 0.00 ~ 6.45% at a phenolic concentration of 50 ~ 200 ㎍ / mL, ethanol extract (GPE) of greenball apple peel ) Showed an inhibitory effect of 13.16-20.78% at a phenolic concentration of 50-200 ㎍ / mL. In addition, the water extract (BPW) of the adverb varietal bark used as a control showed an inhibitory effect of 0.03-1.79% at a phenolic concentration of 50-200 ㎍ / mL, and 50-200 ㎍ in the ethanol extract (BPE) of the adverb varietal bark. phenolic concentration of 1.29 ~ 12.72%, green ball apple peel extract showed better anti-inflammatory effect than adverb shell extract, especially ethanol extract showed higher anti-inflammatory effect than adverb. Indicated.
따라서, 상기 결과로부터 그린볼 사과 껍질추출물은 항염증, 아토피 억제효과를 활용한 기능성 제품에 적용이 가능할 것으로 판단되었다. Therefore, from the above results, it was determined that the greenball apple peel extract could be applied to a functional product utilizing anti-inflammatory and atopic inhibitory effects.
실험예Experimental Example 6. 6. 그린볼Green Ball 사과 껍질추출물의 주름개선 효과 확인 Confirmation of wrinkle improvement of apple peel extract
6-1.6-1. ElastaseElastase 저해 효과 확인 Confirmation of inhibitory effect
인체의 피부탄력을 유지해주는 elastin을 분해하여 피부 주름을 생성시키는 효소인 elastase의 저해 효과를 상기 실시예 2-7의 방법으로 측정한 결과, 도 10a에 나타낸 바와 같이 그린볼 사과 껍질의 water 추출물(GPW)에서는 50~200 ㎍/mL의 phenolic 농도에서 3.90~4.55%의 저해 효과를 나타내었고, 그린볼 사과 껍질의 ethanol 추출물(GPE)에서는 50~200 ㎍/mL의 phenolic 농도에서 29.39~63.38%의 비교적 높은 저해 효과를 나타내었다. 또한, 대조군으로 사용한 부사 품종의 껍질 water 추출물(BPW)은 50~200 ㎍/mL의 phenolic 농도에서 0.00~5.35%의 저해 효과를 나타내었고, 부사 껍질 ethanol 추출물(BPE)에서는 50~200 ㎍/mL의 phenolic 농도에서 8.02~32.10%의 저해 효과를 나타내어, 그린볼 사과 껍질추출물의 elastase 저해 효과가 더 우수한 것을 확인하였다. As a result of measuring the inhibitory effect of elastase, an enzyme that decomposes elastin to maintain skin elasticity of the human body and produces skin wrinkles, the water extract of greenball apple peel as shown in FIG. GPW) showed 3.90 ~ 4.55% inhibitory effect at phenolic concentration of 50 ~ 200 ㎍ / mL, and 29.39 ~ 63.38% at phenolic concentration of 50 ~ 200 ㎍ / mL in ethanol extract (GPE) of greenball apple peel. It showed a relatively high inhibitory effect. In addition, the bark water extract (BPW) of the adverb varieties used as a control showed an inhibitory effect of 0.00 ~ 5.35% at a phenolic concentration of 50-200 ㎍ / mL, and 50-200 ㎍ / mL in the ethanol extract (BPE). In the phenolic concentration of 8.02 ~ 32.10% showed an inhibitory effect, it was confirmed that the elastase inhibitory effect of Greenball apple peel extract is better.
6-2.6-2. CollagenaseCollagenase 저해 효과 확인 Confirmation of inhibitory effect
Collagen을 분해하는 enzyme인 collagenase의 저해효과를 상기 실시예 2-8의 방법으로 측정한 결과, 도 10b에 나타낸 바와 같이 그린볼 사과 껍질의 water 추출물(GPW)에서는 50~200 ㎍/mL의 phenolic 농도에서 8.44~40.06%의 저해 효과를 나타내었고, 그린볼 사과 껍질의 ethanol 추출물(GPE)에서는 50~200 ㎍/mL의 phenolic 농도에서 44.66~80.07%의 저해 효과를 나타내었다. 또한, 대조군으로 사용한 부사 품종의 껍질 water 추출물(BPW)은 50~200 ㎍/mL의 phenolic 농도에서 25.89~59.73%의 저해 효과를 나타내었고, 부사 껍질 ethanol 추출물(BPE)에서는 50~200 ㎍/mL의 phenolic 농도에서 47.79~79.05%의 저해 효과를 나타내어, 그린볼 사과 껍질의 ethanol 추출물이 100~150 μg/mL phenolic 농도범위에서 부사 품종에 비해 상대적으로 더 우수한 collagenase 저해 효과를 가지는 것을 확인하였다.As a result of measuring the inhibitory effect of collagenase, an enzyme that degrades collagen, by the method of Example 2-8, as shown in FIG. 10B, the water extract (GPW) of greenball apple peel shows a phenolic concentration of 50-200 ㎍ / mL. Showed an inhibitory effect of 8.44 ~ 40.06%, and ethanol extract (GPE) of greenball apple peel showed 44.66 ~ 80.07% of inhibitory effect at 50 ~ 200 ㎍ / mL phenolic concentration. In addition, the water extract (BPW) of the adverb varieties used as a control showed an inhibitory effect of 25.89-59.73% at a phenolic concentration of 50-200 ㎍ / mL, and 50-200 ㎍ / mL in the adverb shell ethanol extract (BPE). In the phenolic concentration of 47.79 ~ 79.05% inhibitory effect, it was confirmed that the ethanol extract of greenball apple peel has a better collagenase inhibitory effect than the adverb varieties in the 100 ~ 150 μg / mL phenolic concentration range.
따라서, 상기 결과로부터 그린볼 사과 껍질추출물은 피부 탄력을 유지하는데 중요한 단백질인 elastin과 collagen을 분해하여 주름 유발에 영향을 미치는 enzyme인 elastase 및 collagenase를 억제하여 피부 주름개선 효과에 긍정적인 효과를 미치는 것으로 확인되었다.Therefore, Greenball apple peel extract from the above results to inhibit the elastase and collagenase enzymes affecting wrinkles by decomposing elastin and collagen, which are important proteins for maintaining skin elasticity, have a positive effect on skin wrinkle improvement effect Confirmed.
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시 양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.The specific parts of the present invention have been described in detail above, and it is apparent to those skilled in the art that such specific descriptions are merely preferred embodiments, and thus the scope of the present invention is not limited thereto. something to do. Therefore, the substantial scope of the present invention will be defined by the appended claims and their equivalents.
Claims (15)
Antioxidant for containing green ball apple peel extract as an active ingredient; Anti-inflammatory; Or anti-wrinkle pharmaceutical composition.
상기 조성물은 1,1-디페닐-2-피크릴하이드라질(1,1-diphenyl-2-picrylhydrazyl; DPPH) 라디칼 저해, 2,2'-아지노비스-(3-에틸벤조티아졸린-6-설폰산)(2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid; ABTS) 라디칼 저해, 티오바르비튜릭산 반응성 물질(Thiobarbituric acid reactive substances; TBARs) 저해 또는 항산화물질 보호 인자(Antioxidant protection factor; PF)를 증가시키는 것을 특징으로 하는, 약학적 조성물.
The method of claim 1,
The composition contains 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical inhibition, 2,2'-azinobis- (3-ethylbenzothiazoline-6- Sulfonic acid) (2,2'-Azinobis- (3-ethylbenzothiazoline-6-sulfonic acid; ABTS) radical inhibition, Thiobarbituric acid reactive substances (TBARs) inhibition or antioxidant protection factor PF), pharmaceutical composition.
상기 조성물은 히알루로니다아제(hyaluronidase)를 저해하는 것을 특징으로 하는, 약학적 조성물.
The method of claim 1,
The composition is characterized by inhibiting hyaluronidase (hyaluronidase), pharmaceutical composition.
상기 조성물은 엘라스타아제(elastase) 또는 콜라게나아제(collagenase)를 저해하는 것을 특징으로 하는, 약학적 조성물.
The method of claim 1,
The composition is characterized in that it inhibits elastase or collagenase (collagenase), pharmaceutical composition.
상기 그린볼 사과 껍질추출물은 물, C1내지 C4의 저급알코올, n-헥산, 에틸아세테이트, 아세톤, 부틸아세테이트, 1,3-부틸렌 글리콜, 메틸렌클로라이드, 및 이들의 혼합용매로 구성된 군으로부터 선택된 용매로 추출된 것을 특징으로 하는, 약학적 조성물.
The method of claim 1,
The greenball apple peel extract is selected from the group consisting of water, C 1 to C 4 lower alcohols, n-hexane, ethyl acetate, acetone, butyl acetate, 1,3-butylene glycol, methylene chloride, and mixed solvents thereof. Pharmaceutical composition, characterized in that extracted with a selected solvent.
Antioxidant for containing green ball apple peel extract as an active ingredient; Anti-inflammatory; Or functional food composition for wrinkle improvement.
상기 조성물은 1,1-디페닐-2-피크릴하이드라질(1,1-diphenyl-2-picrylhydrazyl; DPPH) 라디칼 저해, 2,2'-아지노비스-(3-에틸벤조티아졸린-6-설폰산)(2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid; ABTS) 라디칼 저해, 티오바르비튜릭산 반응성 물질(Thiobarbituric acid reactive substances; TBARs) 저해 또는 항산화물질 보호 인자(Antioxidant protection factor; PF)를 증가시키는 것을 특징으로 하는, 건강기능식품 조성물.
The method of claim 6,
The composition contains 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical inhibition, 2,2'-azinobis- (3-ethylbenzothiazoline-6- Sulfonic acid) (2,2'-Azinobis- (3-ethylbenzothiazoline-6-sulfonic acid; ABTS) radical inhibition, Thiobarbituric acid reactive substances (TBARs) inhibition or antioxidant protection factor PF), nutraceutical composition, characterized in that to increase.
상기 조성물은 히알루로니다아제(hyaluronidase)를 저해하는 것을 특징으로 하는, 건강기능식품 조성물.
The method of claim 6,
The composition is characterized by inhibiting hyaluronidase (hyaluronidase), dietary supplement composition.
상기 조성물은 엘라스타아제(elastase) 또는 콜라게나아제(collagenase)를 저해하는 것을 특징으로 하는, 건강기능식품 조성물.
The method of claim 6,
The composition is characterized in that it inhibits elastase or collagenase (collagenase), dietary supplement composition.
상기 그린볼 사과 껍질추출물은 물, C1내지 C4의 저급알코올, n-헥산, 에틸아세테이트, 아세톤, 부틸아세테이트, 1,3-부틸렌 글리콜, 메틸렌클로라이드, 및 이들의 혼합용매로 구성된 군으로부터 선택된 용매로 추출된 것을 특징으로 하는, 건강기능식품 조성물.
The method of claim 6,
The greenball apple peel extract is selected from the group consisting of water, C 1 to C 4 lower alcohols, n-hexane, ethyl acetate, acetone, butyl acetate, 1,3-butylene glycol, methylene chloride, and mixed solvents thereof. Health functional food composition, characterized in that extracted with a selected solvent.
Antioxidant for containing green ball apple peel extract as an active ingredient; Anti-inflammatory; Or cosmetic composition for wrinkle improvement.
상기 조성물은 1,1-디페닐-2-피크릴하이드라질(1,1-diphenyl-2-picrylhydrazyl; DPPH) 라디칼 저해, 2,2'-아지노비스-(3-에틸벤조티아졸린-6-설폰산)(2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid; ABTS) 라디칼 저해, 티오바르비튜릭산 반응성 물질(Thiobarbituric acid reactive substances; TBARs) 저해 또는 항산화물질 보호 인자(Antioxidant protection factor; PF)를 증가시키는 것을 특징으로 하는, 화장료 조성물.
The method of claim 11,
The composition contains 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical inhibition, 2,2'-azinobis- (3-ethylbenzothiazoline-6- Sulfonic acid) (2,2'-Azinobis- (3-ethylbenzothiazoline-6-sulfonic acid; ABTS) radical inhibition, Thiobarbituric acid reactive substances (TBARs) inhibition or antioxidant protection factor PF) to increase the cosmetic composition.
상기 조성물은 히알루로니다아제(hyaluronidase)를 저해하는 것을 특징으로 하는, 화장료 조성물.
The method of claim 11,
The composition is characterized in that to inhibit hyaluronidase (hyaluronidase), cosmetic composition.
상기 조성물은 엘라스타아제(elastase) 또는 콜라게나아제(collagenase)를 저해하는 것을 특징으로 하는, 화장료 조성물.
The method of claim 11,
The composition is characterized in that it inhibits elastase or collagenase, the cosmetic composition.
상기 그린볼 사과 껍질추출물은 물, C1내지 C4의 저급알코올, n-헥산, 에틸아세테이트, 아세톤, 부틸아세테이트, 1,3-부틸렌 글리콜, 메틸렌클로라이드, 및 이들의 혼합용매로 구성된 군으로부터 선택된 용매로 추출된 것을 특징으로 하는, 화장료 조성물.
The method of claim 11,
The greenball apple peel extract is selected from the group consisting of water, C 1 to C 4 lower alcohols, n-hexane, ethyl acetate, acetone, butyl acetate, 1,3-butylene glycol, methylene chloride, and mixed solvents thereof. Cosmetic composition, characterized in that extracted with a selected solvent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180086094A KR102144677B1 (en) | 2018-07-24 | 2018-07-24 | Composition for anti-oxidation, anti-inflammation, or anti-wrinkle comprising extract of Greenball apple peel |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180086094A KR102144677B1 (en) | 2018-07-24 | 2018-07-24 | Composition for anti-oxidation, anti-inflammation, or anti-wrinkle comprising extract of Greenball apple peel |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200011243A true KR20200011243A (en) | 2020-02-03 |
KR102144677B1 KR102144677B1 (en) | 2020-08-14 |
Family
ID=69627113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180086094A KR102144677B1 (en) | 2018-07-24 | 2018-07-24 | Composition for anti-oxidation, anti-inflammation, or anti-wrinkle comprising extract of Greenball apple peel |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102144677B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102456555B1 (en) | 2020-11-25 | 2022-10-19 | 한상철 | Cosmetic composition comprising extract of crude drug complex for anti-wrinkle |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120108930A (en) * | 2011-03-23 | 2012-10-05 | 가부시키가이샤 블룸 클래식 | Antioxidants and skin cosmetics |
KR20160044642A (en) * | 2014-10-15 | 2016-04-26 | 동의대학교 산학협력단 | Composition for improving skin wrinkle comprising extract or compounds derived from unripe apple |
KR20180065798A (en) * | 2016-12-08 | 2018-06-18 | (주)튜링겐코리아 | A composition for skin whitening, anti-oxidating and anti-wrinkle comprising unripe apple extracts and baicalin |
-
2018
- 2018-07-24 KR KR1020180086094A patent/KR102144677B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120108930A (en) * | 2011-03-23 | 2012-10-05 | 가부시키가이샤 블룸 클래식 | Antioxidants and skin cosmetics |
KR20160044642A (en) * | 2014-10-15 | 2016-04-26 | 동의대학교 산학협력단 | Composition for improving skin wrinkle comprising extract or compounds derived from unripe apple |
KR20180065798A (en) * | 2016-12-08 | 2018-06-18 | (주)튜링겐코리아 | A composition for skin whitening, anti-oxidating and anti-wrinkle comprising unripe apple extracts and baicalin |
Non-Patent Citations (2)
Title |
---|
J. Korean Soc. Appl. Biol. Chem. 2015, Vol. 58, No. 2, pp. 249-256 * |
J. of Korean Oil Chemists’ Soc. 2016, Vol. 33, No. 1, pp. 186-194* * |
Also Published As
Publication number | Publication date |
---|---|
KR102144677B1 (en) | 2020-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102110902B1 (en) | Composition for anti-oxidation, anti-inflammation, anti-diabetes, whitening, anti-wrinkle, or anti-gout comprising extract of Ruby-S apple peel | |
KR20210087405A (en) | Compositions Containing Plant Extracts | |
KR101263547B1 (en) | Cosmetic composition comprising green tea seed coater extract having anti-oxidative or anti-inflammatory activity | |
KR101229045B1 (en) | Extracting method of nelumbo nucifera flower, leaf, stem, root, seed and cosmetic composition for anti-wrinkle containing extracts thereby | |
KR102568108B1 (en) | Cosmetic composition comprising Potentilla glabra extract as an active ingredient | |
KR20120122509A (en) | A whitening composition comprising salicornia herbacea extract | |
KR20200040606A (en) | Composition for anti-oxidation, anti-diabetes, pore shrink or anti-wrinkle comprising extract of Arisoo apple | |
KR102144677B1 (en) | Composition for anti-oxidation, anti-inflammation, or anti-wrinkle comprising extract of Greenball apple peel | |
KR102320424B1 (en) | Cosmetic composition for anti-wrinkle and whitening comprising Lilium longiflorum extract and Allium hookeri extract as active ingredients | |
KR102258379B1 (en) | Method for increasing anti-inflammation, whitening, or anti-wrinkle activity of Oplismenus undulatifolius using elicitor | |
KR20200040607A (en) | Composition for anti-oxidation, anti-inflammation, anti-diabetes, pore shrink, or anti-wrinkle comprising extract of Summer prince apple | |
KR20200040608A (en) | Composition for anti-oxidation, anti-inflammation, anti-diabetes, whitening, anti-wrinkle, or anti-gout comprising extract of Honggeum apple peel | |
KR102139156B1 (en) | Composition Comprising Enzyme Treated Extract of Red Ginseng and Gastrodia for Preventing or Improving Skin Wrinkle as Active Ingredient | |
KR102202174B1 (en) | Composition for skin whitening comprising extract of Ruby-S apple peel as an active ingredient | |
KR20210123548A (en) | Improvement composition for Hot flash comprising the extract of Salvia miltiorrhiza as an active ingredient | |
KR20210032370A (en) | Composition for anti-oxidation, anti-inflammation, anti-diabetes, or anti-wrinkle comprising extract of Hwangok apple peel | |
KR20210032369A (en) | Composition for anti-oxidation, anti-inflammation, anti-diabetes, whitening, anti-wrinkle, or anti-gout comprising extract of Honggeum apple peel | |
KR20210032368A (en) | Composition for anti-oxidation, anti-inflammation, anti-diabetes, or anti-wrinkle comprising extract of Summer king apple peel | |
KR20200046524A (en) | Composition for anti-oxidation, anti-inflammation, anti-diabetes, or anti-wrinkle comprising extract of Hwangok apple peel | |
KR20200040605A (en) | Composition for anti-oxidation, anti-inflammation, anti-diabetes, or anti-wrinkle comprising extract of Summer king apple peel | |
KR102104803B1 (en) | Composition Comprising Gingenoside F2 and 4-α-D-Glucopyranosyloxy Benzyl Alcohol for Preventing or Improving Skin Wrinkle as Active Ingredient | |
KR102295919B1 (en) | Cosmetic Composition comprising Licania macrocarpa extract as active ingredient | |
KR102561258B1 (en) | Composition for controlling sebum and improving pore comprising Jasminum Officinale, Salix Alba (willow) bark and Solanum melogena fruit extract | |
KR102334144B1 (en) | Antioxidant Cosmetic composition comprising extract of Lycopus maackianus | |
KR102334154B1 (en) | Antioxidant Cosmetic composition comprising extract of Callicarpa mollis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |